As filed with the Securities and Exchange Commission on June 28, 2019
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[X] | Preliminary Proxy Statement |
[ ] | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
[ ] | Definitive Proxy Statement |
[ ] | Definitive Additional Materials |
[ ] | Soliciting Material under Rule 14a-12 |
COPLEY FUND, INC.
(Name of Registrant as Specified In Its Charter)
Not Applicable
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[ ] | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11 |
| (1) | Title of each class of securities to which transaction applies: |
| (2) | Aggregate number of securities to which transaction applies: |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11(Set forth the amount on which the filing fee is calculated and state how it was determined): |
| (4) | Proposed maximum aggregate value of transaction: |
| (5) | Total fee paid: |
| | |
[ ] | Fee paid previously with preliminary materials. |
[ ] | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| (1) | Amount Previously Paid: |
| (2) | Form, Schedule or Registration Statement No.: |
| (3) | Filing Party: |
| (4) | Date Filed: |
Proxy Statement
[___], 2019
Important Voting Information Inside
Copley Fund, Inc. (COPLX)
Please vote immediately!
You can vote through the internet, by telephone, or
by mail. Details on voting can be found on
your proxy card.
Copley Fund, Inc.
5348 Vegas Drive, Suite 391
Las Vegas, NV 89108
SPECIAL MEETING OF SHAREHOLDERS
Important Voting Information Inside!
TABLE OF CONTENTS
Letter from the President | 4 |
Notice of Special Meeting of Shareholders | 7 |
Important Information to Help You Understand the Proposals | 9 |
Proxy Statement | 15 |
Proposal 1: To approve a proposed advisory agreement to be entered into by and between Copley Fund, Inc. and Copley Financial Services Corp. | |
Proposal 2: To approve a proposed new sub-advisory agreement to be entered into by and among Copley Fund, Inc., Copley Financial Services Corp. and DCM Advisors, LLC | |
Proposal 3: To elect three director nominees to serve on the Board of Directors | |
Proposal 4: To ratify the appointment of the independent registered public accounting firm for the Copley Fund, Inc. | |
Proposal 5: To transact any other business that may properly come before the Meeting or any adjournment thereof in the discretion of the proxies or their substitutes | |
Additional Information Regarding Shareholders and Voting Requirements | 31 |
Additional Information Regarding the Operation of the Fund | 32 |
Other Matters | 35 |
Exhibit A: Form of the proposed advisory agreement to be entered into by and between Copley Fund, Inc. and Copley Financial Services Corp. |
Exhibit B: Form of the proposed new sub-advisory agreement to be entered into by and among Copley Fund, Inc., Copley Financial Services Corp., and DCM Advisors, LLC |
Form of Proxy Card | |
Copley Fund, Inc.
[__], 2019
Dear Shareholder:
You are cordially invited to attend a Special Meeting of Shareholders (the “Meeting”) of the Copley Fund, Inc. (the “Fund”), to be held at [____] _.m., Eastern time, on [Meeting date], 2019 at the offices of [__________], [address of meeting]. Formal notice of the Meeting appears after this letter, followed by a Proxy Statement.
At the Meeting, shareholders will be asked to vote on a proposal to approve the investment advisory agreement on behalf of the Fund, to approve a new sub-advisory agreement on behalf of the Fund, to elect three directors to serve on the Board of Directors of the Fund, to ratify the appointment of the Fund’s independent registered public accounting firm and to transact any other business that may properly come before the Meeting. We hope that you can attend the Meeting in person; however, we urge you in any event to vote your shares by completing and returning the enclosed proxy card in the envelope provided, or by voting by telephone or through the internet at your earliest convenience.
As you may know, Mr. Irving Levine, the Fund’s portfolio manager of over 40 years and the principal of Copley Financial Services Corp, the Fund’s investment adviser (the “Adviser”), passed away in May of 2018. The Adviser has continued to manage the Fund in the same manner as it was operated prior to Mr. Levine’s death and employed appropriate personnel to do so.
The Board determined, after careful consideration, that the interests of the Fund and its shareholders would be best served by the selection of a sub-adviser to assist the Adviser with the day-to-day management of the Fund’s portfolio, with the Adviser supervising the activities of the sub-adviser and continuing to provide general managerial services to the Fund. The Board performed an independent search for a suitable sub-adviser. After careful consideration, including a series of meetings and a detailed review of information provided by the proposed investment sub-adviser, the Board recommends DCM Advisors, LLC (the “Sub-Adviser” or “DCM”) as the sub-adviser for the Fund according to the terms of the proposed sub-advisory agreement by and among the Fund, the Adviser and DCM (the “Sub-Advisory Agreement”). DCM’s engagement as sub-adviser has been approved by the Board, but remains subject to shareholder approval.
DCM is registered with the U.S. Securities and Exchange Commission and is located in New York City. DCM currently serves as the investment adviser to another mutual fund. In addition, DCM, along with its employees and affiliates, has significant experience in managing investments for other clients, including individuals, corporations, non-taxable entities, and other entities. Additional information about DCM is described in the Proxy Statement.
In anticipation of the Board’s approval of DCM as Sub-Adviser, the Adviser hired Dr. Vijay Chopra, who is a Senior Portfolio Manager at DCM, and appointed Dr. Chopra as Vice President of the Adviser. The Adviser also appointed Dr. Chopra as Portfolio Manager of the Fund, which the Board subsequently ratified. Since April 1, 2019, Dr. Chopra has been serving as Portfolio Manager of the Fund.
The Board now seeks shareholder approval of the Sub-Advisory Agreement. Pursuant to the Sub-Advisory Agreement, the Adviser (and not the Fund) will pay the Sub-Adviser for its services, which fee will be equal to a percentage of the fee payable to the Adviser under the Advisory Agreement. The Fund will not experience an increase in fees as a result of the Sub-Advisory Agreement. If the Advisory Agreement and the Sub-Advisory Agreement are approved by the Fund’s shareholders, then the Sub-Advisory Agreement, which will have an initial term of 2 years and which may be extended by the Board on an annual basis thereafter, will be effective immediately upon the final adjournment of the Meeting. Dr. Chopra is expected to remain as Portfolio Manager of the Fund under the Sub-Advisory Agreement.
After careful consideration, the Board has unanimously approved the Sub-Advisory Agreement and recommends that you vote “FOR” approval of the Sub-Advisory Agreement for the Fund.
The Board also seeks shareholder approval of a new investment advisory agreement between the Fund and the Adviser. Under the Investment Company Act of 1940, as amended (the “Investment Company Act”), an investment advisory agreement automatically terminates upon an “assignment”, which includes any transfer of a controlling block of the investment adviser’s outstanding voting securities. The death or Mr. Levine, the sole owner of the Adviser, and the resulting transfer of his ownership interest in the Adviser to his estate may be considered to have resulted in an “assignment” under applicable law. As a result, the Board now requests that shareholders approve a new advisory agreement between the Fund and the Adviser (the “Advisory Agreement”), which will be on substantially the same terms as the former investment advisory agreement (the “Former Advisory Agreement”).
After careful consideration, the Board has unanimously approved the Advisory Agreement and recommends that you vote “FOR” approval of the Advisory Agreement for the Fund.
The Board is also asking shareholders to vote to elect the current members of the Fund’s Board of Directors for continued service on the Board. The current members of the Board are Mr. Gary S. Gaines, Mr. Roy G. Hale, and Mr. David I. Faust (the “Directors”). Mr. Gaines and Mr. Hale are both independent directors (i.e., not “interested persons” as defined in the Investment Company Act). Mr. Gaines has been a director of the Fund since 2009 and currently serves as the Lead Independent Director. Mr. Hale has served as a director since 2011 and serves as the President and Treasurer of the Fund. Mr. Hale previously served as the auditor of the Fund from 1991 through 2008. Mr. Faust is an interested Director as a result of his relationship with the Adviser, which is described in the Proxy Statement. The Board has determined to submit the Directors as nominees (each a “Nominee”) for shareholder approval at this Meeting. The Board made this determination based on its conclusion that each Nominee has satisfactory qualifications, and that the Nominees collectively provide a diversity of both relevant professional expertise and social perspective that will contribute to the Board’s operations
The Board unanimously recommends that you vote “FOR” the election of each of the Nominees as Directors of the Fund.
As a matter of good corporate governance, the Fund is also asking shareholders to ratify the appointment by the Board of EisnerAmper LLP as the independent registered public accounting firm for the Fund for the fiscal year ending February 29, 2020. EisnerAmper LLP has served as the Fund’s independent registered public accounting firm since 2010.
The Board unanimously recommends that you vote “FOR” the ratification of the Fund’s independent registered public accounting firm.
Your vote is important regardless of the number of shares you own. In order to avoid the added cost of follow-up solicitations and possible adjournments, please take a few minutes to read the Proxy Statement and cast your vote. It is important that your vote be received no later than 11:59 p.m., Eastern time, on [____________], 2019.
You may cast your vote by signing, dating, and mailing the enclosed proxy card in the postage prepaid return envelope provided. In addition to voting by mail you may also vote either by telephone or through the internet as follows:
TO VOTE BY TELEPHONE: | | TO VOTE BY INTERNET: |
1) Read the Proxy Statement and have the enclosed proxy card at hand | | 1) Read the Proxy Statement and have the enclosed proxy card at hand |
2) Call the toll-free number that appears on the enclosed proxy card and follow the simple instructions | | 2) Go to the website that appears on the enclosed proxy card and follow the simple instructions |
Although you may vote in person at the Meeting, you are encouraged to vote by telephone or through the internet using the control number that appears on the enclosed proxy card. Use of telephone or internet voting will reduce the time and costs associated with this proxy solicitation. Whichever method you choose, please read the enclosed Proxy Statement carefully before you vote.
We appreciate your participation and prompt response in this matter and thank you for your continued support. If you have any questions after considering the enclosed materials, please call [proxy solicitor], the Fund’s proxy solicitor, toll free at [proxy solicitor phone #].
| Sincerely, |
| |
| Roy G. Hale, President, Copley Fund, Inc. |
COPLEY FUND, INC.
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SHAREHOLDER MEETING TO BE HELD AT [___] _.M., EASTERN TIME, ON [MEETING DATE], 2019. THE PROXY STATEMENT TO SHAREHOLDERS IS AVAILABLE AT[WEBSITE] OR BY CALLING [PROXY SOLICITOR] TOLL FREE AT [PROXY SOLICITOR PHONE #]. |
To the Shareholders of the Copley Fund, Inc.:
NOTICE IS HEREBY GIVEN that a Special Meeting of Shareholders (the “Meeting”) of the Copley Fund, Inc. (the “Fund”), will be held at the offices of [_______], [Meeting Address] at [___] _.m., Eastern time, on [Meeting Date], 2019. The purpose of the Meeting is to consider and vote on the following proposals (the “Proposals”; each a “Proposal”):
| 1. | To approve a proposed advisory agreement (the “Advisory Agreement”) to be entered into by and between the Fund and Copley Financial Services Corp. (the “Adviser”) |
| 2. | To approve a proposed new sub-advisory agreement (the “Sub-Advisory Agreement”) to be entered into by and among the Fund, the Adviser and DCM Advisors, LLC (the “Sub-Adviser”) |
| 3. | To elect three director nominees (the “Nominees”) to serve on the Board of Directors |
| 4. | To ratify the appointment of the independent registered public accounting firm (the “Auditor”) for the Fund |
| 5. | To transact any other business that may properly come before the Meeting or any adjournment thereof in the discretion of the proxies or their substitutes |
It is not anticipated that any matter other than the approval of the Advisory Agreement and Sub-Advisory Agreement, the election of the Nominees and the ratification of the appointment of the Auditor will be brought before the Meeting. Shareholders of record of the Fund as of the close of business on [Record Date], 2019, will be entitled to notice of and to vote at the Meeting or any adjournment thereof. A Proxy Statement and proxy card solicited by the Fund are included herewith. If you need directions to the Meeting, please call the [proxy solicitor], the Fund’s proxy solicitor, at the number stated above.
The Board of Directors of the Fund has approved the Advisory Agreement and the Sub-Advisory Agreement, the election of the Nominees, and the selection of the Auditor and recommends that you vote “FOR” each of the Proposals.
YOUR VOTE IS IMPORTANT. PLEASE VOTE BY TELEPHONE OR THROUGH THE INTERNET BY FOLLOWING THE INSTRUCTIONS ON YOUR PROXY CARD TO AVOID UNNECESSARY EXPENSE AND DELAY. YOU MAY ALSO EXECUTE THE ENCLOSED PROXY AND RETURN IT PROMPTLY IN THE ENCLOSED ENVELOPE. NO POSTAGE IS REQUIRED IF MAILED IN THE UNITED STATES. THE PROXY IS REVOCABLE AND WILL NOT AFFECT YOUR RIGHT TO VOTE IN PERSON IF YOU ATTEND THE MEETING.
| By order of the Board of Directors, |
| |
| David Faust |
| Secretary, Copley Fund, Inc. |
Dated: [_______], 2019
IMPORTANT INFORMATION TO HELP YOU UNDERSTAND THE PROPOSALS
You should carefully read the entire text of the Proxy Statement. We have provided you with the following questions and answers to give you a general overview of some of the important information in the Proxy Statement.
QUESTIONS AND ANSWERS
Q. What is happening? Why did I get this package of materials?
A. You are receiving the enclosed Proxy Statement as a shareholder of the Copley Fund, Inc. (the “Fund”), in connection with a special meeting of shareholders of the Fund (the “Meeting”) scheduled to be held at [___] _.m., Eastern Time, on [Meeting Date], 2019. All holders of Fund shares as of the close of business on [Record Date], 2019 (the “Record Date”), are entitled to attend and vote at the Meeting.
Q: What am I being asked to vote on?
A: You are being asked to approve the following proposals (the “Proposals” and each a “Proposal”):
| 1. | To approve a proposed advisory agreement (the “Advisory Agreement”) to be entered into by and between Copley Fund, Inc. and Copley Financial Services Corp. (the “Adviser” or “CFSC”) |
| 2. | To approve a proposed new sub-advisory agreement (the “Sub-Advisory Agreement”) to be entered into by and among the Fund, the Adviser and DCM Advisors, LLC (the “Sub-Adviser” or “DCM”) |
| 3. | To elect three director nominees (the “Nominees”) to serve on the Board of Directors |
| 4. | To ratify the appointment of the independent registered public accounting firm (the “Auditor”) for the Fund |
| 5. | To transact any other business that may properly come before the Meeting or any adjournment thereof in the discretion of the proxies or their substitutes |
Q. How does the Board of Directors of the Fund (the “Board” or the “Board of Directors”) recommend that I vote with respect to each Proposal?
A. After careful consideration of the Proposals, the Board, including each of the Independent Directors, unanimously recommends that you vote FOR each of the Proposals.
Q: Why am I being asked to vote on the Advisory Agreement and the Sub-Advisory Agreement?
A: As you may know, Mr. Irving Levine, the Fund’s portfolio manager of over 40 years and the principal of Copley Financial Services Corp, the Fund’s investment adviser (the “Adviser”), passed away in May of 2018. The Adviser has continued to manage the Fund in the same manner as it was operated prior to Mr. Levine’s death and employed appropriate personnel to do so.
The Board determined, after careful consideration, that the interests of the Fund and its shareholders would be best served by the selection of a sub-adviser to assist the Adviser with the day-to-day management of the Fund’s portfolio, with the Adviser supervising the activities of the sub-adviser and continuing to provide general managerial services to the Fund. The Board performed an independent search for a suitable sub-adviser. After careful consideration, including a series of meetings and a detailed review of information provided by the proposed investment sub-adviser, the Board recommends DCM Advisors, LLC (the “Sub-Adviser” or “DCM”) as the sub-adviser for the Fund according to the terms of the proposed sub-advisory agreement by and among the Fund, the Adviser and DCM (the “Sub-Advisory Agreement”). DCM’s engagement as sub-adviser has been approved by the Board, but remains subject to shareholder approval.
DCM is registered with the U.S. Securities and Exchange Commission and is located in New York City. DCM currently serves as the investment adviser to another mutual fund. In addition, DCM, along with its employees and affiliates, has significant experience in managing investments for other clients, including individuals, corporations, non-taxable entities, and other entities. Additional information about DCM is described in the Proxy Statement.
In anticipation of the Board’s approval of DCM as Sub-Adviser, the Adviser hired Dr. Vijay Chopra, who is a Senior Portfolio Manager at DCM, and appointed Dr. Chopra as Vice President of the Adviser. The Adviser also appointed Dr. Chopra as Portfolio Manager of the Fund, which the Board subsequently ratified. Since April 1, 2019, Dr. Chopra has been serving as Portfolio Manager of the Fund.
The Board now seeks shareholder approval of the Sub-Advisory Agreement. Pursuant to the Sub-Advisory Agreement, the Adviser (and not the Fund) will pay the Sub-Adviser for its services, which fee will be equal to a percentage of the fee payable to the Adviser under the Advisory Agreement. The Fund will not experience an increase in fees as a result of the Sub-Advisory Agreement. If the Advisory Agreement and the Sub-Advisory Agreement are approved by the Fund’s shareholders, then the Sub-Advisory Agreement, which will have an initial term of 2 years and which may be extended by the Board on an annual basis thereafter, will be effective immediately upon the final adjournment of the Meeting. Dr. Chopra is expected to remain as Portfolio Manager of the Fund under the Sub-Advisory Agreement.
The Board also seeks shareholder approval of a new investment advisory agreement between the Fund and the Adviser. Under the Investment Company Act of 1940, as amended (the “Investment Company Act”), an investment advisory agreement automatically terminates upon an “assignment”, which includes any transfer of a controlling block of the investment adviser’s outstanding voting securities. The death or Mr. Levine, the sole owner of the Adviser, and the resulting transfer of his ownership interest in the Adviser to his estate may be considered to have resulted in an “assignment” under applicable law. As a result, the Board now requests that shareholders approve a new advisory agreement between the Fund and the Adviser (the “Advisory Agreement”), which will be on the same terms as the former investment advisory agreement (the “Former Advisory Agreement”), except for the date of the agreement and its term.
Q. Does the Board of Directors recommend that shareholders vote to approve the Advisory Agreement and the Sub-Advisory Agreement?
A. Yes, the Board of Directors unanimously recommends that the shareholders of the Fund vote to approve each of the Advisory Agreement and the Sub-Advisory Agreement. The various factors the Board of Directors considered in making these determinations are described in the Proxy Statement.
Q: When would the Advisory Agreement and the Sub-Advisory Agreement take effect?
A:If approved by the Fund’s shareholders, the Advisory Agreement and the Sub-Advisory Agreement would take effect immediately.
Q: Will the approval of the Advisory Agreement and/or the Sub-Advisory Agreement increase the fees payable by the Fund under the Former Advisory Agreement?
A: No. The advisory fee payable by the Fund to the Adviser under the Advisory Agreement will be equal to the advisory fee payable to the Adviser under the Former Advisory Agreement. In addition, the Adviser expects to continue to waive a portion of the advisory fee otherwise payable by the Fund, as it has historically done and as is further described in the Proxy Statement, but the Adviser is not obligated to do so for this or any future year(s). The Sub-Adviser will be paid a portion of the fee received by CFSC under the Advisory Agreement and as such, the Sub-Advisory Agreement will not increase the fees payable by the Fund.
Q: Will the approval of the Advisory Agreement and the Sub-Advisory Agreement change the current management of the Fund?
A: No. Dr. Chopra has served as Portfolio Manager of the Fund since April 1, 2019. Upon the approval of the Advisory Agreement and Sub-Advisory Agreement, it is expected that Dr. Chopra will continue to serve as Portfolio Manager of the Fund.
Q: Why am I being asked to elect Directors?
A: Federal securities laws generally require that a majority of the members of a Fund’s board of directors be elected by shareholders. The members of the Fund’s current Board of Directors (the “Directors”) are Mr. Roy G. Hale, Mr. Gary S. Gaines, and Mr. David I. Faust. The Board has nominated each of Mr. Hale, Mr. Gaines, and Mr. Faust (the “Nominees”) for continued service on the Board. Each of the Nominees has been nominated, in part, because of the Nominee’s experience as a director or trustee for a registered investment company and experience working with the Fund and the Adviser, as well as their knowledge of the Adviser. To ensure compliance with the aforementioned requirements, shareholders are being asked to elect each of Nominees.
Q: What role does the Board play generally?
A:The Directors serve as representatives of the shareholders of the Fund and the Board is generally responsible for governance and oversight of the Fund. The Directors are fiduciaries and have an obligation to serve the best interests of the Fund’s shareholders. The Board meets several times throughout the year to review the Fund’s performance, oversee the Fund’s operations, consider policy changes, and review and approve contractual arrangements between the Fund and companies that provide services to it, including the Fund’s investment adviser.
Q: Who are the nominees for election or reelection to the Board?
A:The Board proposes that the following Directors be elected to continue to serve as Directors of the Fund:
Gary S. Gaines
Roy G. Hale
David I. Faust
Mr. Gaines and Mr. Hale currently serve as independent Directors (i.e., they are not “interested persons” of the Fund, as defined in the Investment Company Act). Mr. Faust is an interested Director due to his relationship with the Adviser.
Q. Does the Board of Directors recommend that shareholders vote to elect the Nominees?
A.Yes, the Board of Directors unanimously recommends that the shareholders vote in favor of all three Nominees. Information regarding the qualifications of each Nominee is set forth in the discussion of Proposal 3 in the Proxy Statement.
Q. Why am I being asked to ratify the appointment of the Auditor?
A. As a matter of good corporate governance, the Fund is also asking shareholders to ratify the appointment by the Board of EisnerAmper LLP as the independent registered public accounting firm for the Fund for the fiscal year ending February 29, 2020. EisnerAmper LLP has served as the Fund’s independent registered public accounting firm since 2010. The Board will determine what action to take with respect to appointing an independent registered public accounting firm for the Fund for future years.
Q: What is the required vote to approve the Proposals?
A: In order to conduct the Meeting, we must have a quorum present by proxy or in person. A quorum is a majority of the outstanding shares entitled to vote. To approve each of the Advisory Agreement and the Sub-Advisory Agreement, the vote of a majority of the outstanding shares of the Fund is required. The vote of a majority of the outstanding shares of the Fund means the vote of the lesser of: (1) 67% or more of the shares of the Fund present or represented by proxy at the Meeting, if the holders of more than 50% of the outstanding shares of the Fund are present or represented by proxy, or (2) more than 50% of the outstanding shares of the Fund. With respect to the election of the Nominees and the ratification of the Auditor, an affirmative vote of more than half of the total votes cast is required. Each whole share is entitled to one vote as to any matter on which it is entitled to vote, and each fractional share shall be entitled to a proportionate fractional vote.
Q: Who is eligible to vote?
A: Shareholders of record of the Fund at the close of business on [Record Date], 2019 are entitled to be present and to vote at the Meeting. Each shareholder is entitled to one vote for each share (and a proportionate fractional vote for each fractional share) held by such shareholder on the Record Date.
Q: How do I vote?
A: You can vote in one of the following four ways:
| 1. | Complete, sign, date and promptly return the enclosed proxy card in the enclosed postage prepaid envelope; |
| 2. | Call the toll-free telephone number found on the enclosed proxy card; |
| 3. | Go to the website found on the enclosed proxy card and enter the control number that appears on the proxy card; or |
| 4. | Attend the Meeting and vote in person. |
Proxy cards that are properly signed, dated and received prior to the Meeting will be voted as specified. If you specify a vote on any Proposal, your proxy will be voted as you indicate, and any Proposals for which you are entitled to vote but for which no vote is specified will be voted FOR that Proposal. If you simply sign, date and return the proxy card, but do not specify a vote on any of the Proposals, your shares will be voted FOR all Proposals.
Q: May I revoke my proxy?
A: You may revoke your proxy at any time prior to use by filing with the Secretary of the Fund an instrument revoking the proxy prior to the Meeting, by submitting a proxy bearing a later date, or by attending and voting at the Meeting.
Q: What will happen if there are not enough votes to have the Meeting?
A: It is important that shareholders vote by telephone or internet or complete and return signed proxy cards promptly, but no later than 11:59 p.m., Eastern time, on [_______], 2019, to ensure there is a quorum for the Meeting. You may be contacted by officers of the Fund or the Adviser, or by [Proxy Solicitor], the Fund’s proxy solicitor, who will assist you in voting your shares. If the Fund has not received sufficient votes to have a quorum at the Meeting or has not received enough votes to approve the Advisory Agreement and Sub-Advisory Agreement, to elect the Directors and to ratify the Auditor, then the Meeting may be adjourned to a later date so we can continue to seek more votes.
Q: What happens if the Proposals are not approved?
A: If the Proposal is not approved with respect to the Fund’s Advisory Agreement, then the Advisory Agreement will not take effect. If the Advisory Agreement is not approved, then the Former Advisory Agreement will continue in effect until its expiration. If the Former Advisory Agreement expires prior to shareholders approving the Advisory Agreement, then the Board will take such action as it deems to be in the best interests of the Fund, which may mean closing and liquidating the Fund. The Proxy Statement contains additional information regarding the Former Advisory Agreement. The effectiveness of the Sub-Advisory Agreement is contingent upon approval of the Advisory Agreement. If the Advisory Agreement is not approved, the Sub-Advisory Agreement will not take effect.
If the Proposal is not approved with respect to the Sub-Advisory Agreement, then the Sub-Advisory Agreement will not take effect. If the Sub-Advisory Agreement is not approved, then the Board will take such action as it deems to be in the best interests of the Fund, which may mean seeking to engage alternative sub-advisers, or closing and liquidating the Fund. The Proxy Statement contains additional information regarding the Sub-Advisory Agreement.
If the Proposal with respect to the election of Directors is not approved, then the Directors will continue to serve as Directors until suitable alternative arrangements can be made or until their resignation or withdrawal as Directors by other means.
Neither the Fund’s Articles of Organization nor its Bylaws require that the shareholders ratify the appointment of the Fund’s independent registered public accounting firm. If the shareholders do not ratify the appointment, the Board will reconsider whether or not to appoint EisnerAmper LLP, but may nonetheless appoint such firm. Even if the appointment is ratified, the Board, in its discretion, may change the appointment at any time during the year if it determines that such change would be in the best interest of the Fund and its shareholders.
Q: Who will pay for the proxy solicitation?
A:The Adviser and Sub-Adviser have agreed to assume the costs, fees and expenses incurred by the Fund in connection with the Meeting and proxy statement, including legal and accounting fees and costs associated with the solicitation of proxies with respect to the Proposals (including the fees of [____] as proxy solicitor). The Fund will not bear any of these costs.
Q: Whom should I call for additional information about the Proxy Statement?
A: If you have any questions regarding the Proxy Statement or completing and returning your proxy card, you can call [proxy solicitor], the Fund’s proxy solicitor, toll free at [proxy solicitor phone #].
COPLEY FUND, INC.
SPECIAL MEETING OF SHAREHOLDERS
To Be Held on [MEETING DATE], 2019
This Proxy Statement is furnished in connection with the solicitation by the Board of Directors (the “Board” or “Board of Directors”) of Copley Fund, Inc., a Nevada corporation (the “Fund”) of proxies for use at the Special Meeting of Shareholders (the “Meeting”) of the Fund, or at any adjournment thereof. The principal mailing address of the Fund is 5348 Vegas Drive, Suite 391, Las Vegas, NV 89108. This Proxy Statement and form of proxy were first mailed to shareholders on or about [__________], 2019.
The Meeting is being held to consider and vote on the following proposals (the “Proposals” and each a “Proposal”):
| 1. | To approve a proposed advisory agreement (the “Advisory Agreement”) to be entered into by and between Copley Fund, Inc. and Copley Financial Services Corp. (the “Adviser” or “CFSC”) |
| 2. | To approve a proposed new sub-advisory agreement (the “Sub-Advisory Agreement”) to be entered into by and among the Fund, the Adviser and DCM Advisors, LLC (the “Sub-Adviser” or “DCM”) |
| 3. | To elect three director nominees (the “Nominees”) to serve on the Board of Directors |
| 4. | To ratify the appointment of the independent registered public accounting firm (the “Auditor”) for the Fund |
| 5. | To transact any other business that may properly come before the Meeting or any adjournment thereof in the discretion of the proxies or their substitutes |
Shareholders of record of the Fund as of the close of business on [Record Date], 2019, are entitled to notice of and to vote at the Meeting or any adjournment thereof.
A proxy, if properly executed, duly returned and not revoked, will be voted in accordance with the specifications therein. A proxy that is properly executed but has no voting instructions with respect to a Proposal will be voted for that Proposal. A shareholder may revoke a proxy at any time prior to use by filing with the Secretary of the Fund an instrument revoking the proxy, by submitting a proxy bearing a later date or by attending and voting at the Meeting.
The Fund has retained [proxy solicitor] to solicit proxies for the Meeting. [Proxy Solicitor] is responsible for printing proxy cards, mailing proxy material to shareholders, soliciting brokers, custodians, nominees, fiduciaries and shareholders, tabulating the returned proxies and performing other proxy solicitation services. The anticipated cost of these services is approximately $[_________], and will be paid by the Sub-Adviser and/or the Adviser.
In addition to solicitation through the mail, proxies may be solicited by officers, employees and agents of the Fund or the Adviser without cost to the Fund, or by [Proxy Solicitor]. Such solicitation may be by telephone, facsimile or otherwise.
| PROPOSAL 1: | TO APPROVE A PROPOSED Advisory AGREEMENT, TO BE ENTERED INTO by and between the Fund and THE ADVISER. |
| PROPOSAL 2: | TO APPROVE A PROPOSED SUB-Advisory AGREEMENT, TO BE ENTERED INTO by and AMONG THE FUND, THE ADVISER and DCM. |
Background.As you may know, Mr. Irving Levine, the Fund’s portfolio manager of over 40 years and the principal of Copley Financial Services Corp, the Fund’s investment adviser (the “Adviser”), passed away in May of 2018. The Adviser has continued to manage the Fund in the same manner as it was operated prior to Mr. Levine’s death and employed appropriate personnel, including certain sub-advisers, to do so.
The Board determined, after careful consideration, that the interests of the Fund and its shareholders would be best served by the selection of a sub-adviser to assist the Adviser with the day-to-day management of the Fund’s portfolio, with the Adviser supervising the activities of the sub-adviser and continuing to provide general managerial services to the Fund. The Board performed an independent search for a suitable sub-adviser. After careful consideration, including a series of meetings and a detailed review of information provided by the proposed investment sub-adviser, the Board recommends DCM Advisors, LLC (the “Sub-Adviser” or “DCM”) as the sub-adviser for the Fund according to the terms of the proposed sub-advisory agreement by and among the Fund, the Adviser and DCM (the “Sub-Advisory Agreement”). DCM’s engagement as sub-adviser has been approved by the Board, but remains subject to shareholder approval.
DCM is registered with the U.S. Securities and Exchange Commission and is located in New York City. DCM currently serves as the investment adviser to another mutual fund. In addition, DCM, along with its employees and affiliates, has significant experience in managing investments for other clients, including individuals, corporations, non-taxable entities, and other entities. Additional information about DCM is described in the Proxy Statement.
In anticipation of the Board’s approval of DCM as Sub-Adviser, the Adviser hired Dr. Vijay Chopra, who is a Senior Portfolio Manager at DCM, and appointed Dr. Chopra as Vice President of the Adviser. The Adviser also appointed Dr. Chopra as Portfolio Manager of the Fund, which the Board subsequently ratified. Since April 1, 2019, Dr. Chopra has been serving as Portfolio Manager of the Fund.
The Board now seeks shareholder approval of the Sub-Advisory Agreement. Pursuant to the Sub-Advisory Agreement, the Adviser (and not the Fund) will pay the Sub-Adviser for its services, which fee will be equal to a percentage of the fee payable to the Adviser under the Advisory Agreement. The Fund will not experience an increase in fees as a result of the Sub-Advisory Agreement. If the Advisory Agreement and the Sub-Advisory Agreement are approved by the Fund’s shareholders, then the Sub-Advisory Agreement, which will have an initial term of 2 years and which may be extended by the Board on an annual basis thereafter, will be effective immediately upon the final adjournment of the Meeting. Dr. Chopra is expected to remain as Portfolio Manager of the Fund under the Sub-Advisory Agreement.
The Board also seeks shareholder approval of a new investment advisory agreement between the Fund and the Adviser. Under the Investment Company Act of 1940, as amended (the “Investment Company Act”), an investment advisory agreement automatically terminates upon an “assignment”, which includes any transfer of a controlling block of the investment adviser’s outstanding voting securities. The death or Mr. Levine, the sole owner of the Adviser, and the resulting transfer of his ownership interest in the Adviser to his estate may be considered to have resulted in an “assignment” under applicable law. As a result, the Board now requests that shareholders approve a new advisory agreement between the Fund and the Adviser (the “Advisory Agreement”), which will be on the same terms as the former investment advisory agreement (the “Former Advisory Agreement”), except for the date of the agreement and its term.
The Former Advisory Agreement.The Former Advisory Agreement, dated September 1, 1978, was approved by the initial shareholder of the Fund on September 1, 1978. The Former Advisory Agreement was last approved by the Board, including a majority of the members of the Board (individually a “Director” and collectively, the “Directors”) who are not interested persons of the Fund, as defined in the Investment Company Act (the “Independent Directors”), at an in-person meeting held on April 12, 2019.
Pursuant to the Former Advisory Agreement, the Adviser provides the following services to the Fund, among others: investment research and advice; management and supervision of the Fund's portfolio of investments; supervision of the Fund’s service providers and certain administrative services.
Under the Former Advisory Agreement, the Adviser receives from the Fund an advisory fee based upon a percentage of the Fund’s daily net assets computed without regard to the assets of the operating business (the assets upon which the fee is computed being hereinafter referred to as the "net securities assets") and is calculated daily and paid monthly as follows: (1) 1.00% of the first $25,000,000 of average daily net securities assets; (2) 0.75% of the next $15,000,000 of average daily net securities assets; and (3) 0.50% of the average daily net securities assets in excess of $40,000,000. The Adviser has historically reduced the amount of the advisory fee to be paid to the Adviser by the Fund by $60,000 on a voluntary basis.
The Advisory Agreement. At the April 12, 2019 meeting of the Board of Directors, the Board, including a majority of the Independent Directors, after careful consideration, approved the Advisory Agreement, subject to the approval of the Fund’s shareholders. Under the Investment Company Act, the Advisory Agreement requires shareholder approval in order to become effective. The terms and conditions of the Advisory Agreement are substantially identical to those of the Former Advisory Agreement.
Investment Management Services.The Adviser has agreed under the Advisory Agreement to provide the same services to the Fund as those provided under the Former Advisory Agreement, including: investment research and advice; management and supervision of the Fund's portfolio of investments; supervision of the Fund’s service providers and certain administrative services. The Adviser expects to delegate responsibility for providing certain of these services to the Sub-Adviser once the Sub-Advisory Agreement is approved by shareholders of the Fund.
Advisory fees. Under the Advisory Agreement, the Adviser will receive an advisory fee from the Fund, computed and accrued daily and paid monthly, which is equal to the advisory fee the Adviser is receiving under the Former Advisory Agreement. The Adviser expects to continue voluntarily waiving a portion of the advisory fee otherwise payable by the Fund, as it has historically done, up to a maximum of $30,000 per year, provided that the Adviser is under no obligation to do so for this or any future year(s).
Term of the Advisory Agreement.If the Advisory Agreement is approved by shareholders of the Fund, it will become effective with respect to the Fund immediately upon the final adjournment of the Meeting. The Advisory Agreement will remain in force for an initial term of two years, and from year to year thereafter, subject to annual approval by: (1) the Board of Directors, or (2) a vote of a majority (as defined in the Investment Company Act) of the outstanding shares of the Fund. In either event, continuance of the Advisory Agreement must also be approved by a majority of the Independent Directors by a vote cast in person at a meeting called for the purpose of voting on the continuance.
Termination.The Advisory Agreement may be terminated at any time, on 60 days’ written notice, without the payment of any penalty, by the Board of Directors or a majority of the shareholders. The Advisory Agreement automatically terminates in the event of its assignment, as defined by the Investment Company Act and the rules thereunder.
Other Information.For the Fund’s fiscal year ended February 28, 2019, the Adviser earned fees in the amount of $638,858, before a voluntarily fee waiver of $60,000. During the Fund’s fiscal year ended February 28, 2019 the Fund paid Gallet Dreyer & Berkey, LLP, the law firm at which Mr. Faust, the control person of the Adviser, is a partner, fees in the aggregate amount of approximately $120,000.00 for legal services. It is expected that Gallet Dreyer & Berkey, LLP will continue to provide these services if the Advisory Agreement is approved. As of the end of the Fund’s fiscal year ended February 28, 2019, the Fund, though its operating division (which is now in the process of being liquidated following the Board’s approval of a plan of liquidation at the April 12, 2019 meeting), owed $48,000 to Stuffco International, Inc., a company that is wholly owned by the estate of Mr. Irving Levine and controlled by Mr. Faust as the Fiduciary of Mr. Levine’s estate, for rent.
The Sub-Advisory Agreement.At the April 12, 2019 meeting of the Board of Directors, the Board, including a majority of the Independent Directors, after careful consideration, approved the Sub-Advisory Agreement, subject to the approval of the Fund’s shareholders. Under the Investment Company Act, the Sub-Advisory Agreement requires shareholder approval in order to become effective. A description of certain of the terms and conditions of the Sub-Advisory Agreement is below.
Services.Pursuant to the Sub-Advisory Agreement, DCM has agreed to provide the following services to the Fund: (a) consult with the Adviser on the investment program for the Fund and what investments or securities will be purchased, retained or sold by the Fund and what portion of the assets belonging to the Fund will be invested or held un-invested as cash; (b) assist the Fund and the Adviser in determining or confirming, consistent with the policies and procedures stated in the Prospectus and SAI or adopted by the Board, the value (including determinations of fair value under the Investment Company Act) of any securities or other instruments held in the Fund; (c) direct the manner in which proxies solicited by issuers of securities beneficially owned by the Fund shall be voted, and make any elections relative to any mergers, acquisitions, tender offers, bankruptcy proceedings or other type events pertaining to the securities held by the Fund; (d) review and comment upon selected portions relating to the Sub-Adviser and/or the strategy in the Prospectus and SAI, and update any information provided in response to a request under this subsection that, to the Sub-Adviser’s knowledge, requires such updating for accuracy from time to time; and (e) participate, at the reasonable request of the Adviser, in educational meetings with placement agents and other intermediaries about portfolio management and investment-related matters of the Fund.
Fee. Under the Sub-Advisory Agreement, the Sub-Adviser will receive a fee from the Adviser (not the Fund) which is equal to a portion (75%) of the advisory fee received by the Adviser under the Advisory Agreement, provided, however, that the Adviser may reduce the advisory fee before calculating the sub-adviser’s fee by deducting certain expenses historically incurred by the Adviser that include the following: administration, account-based and asset-based fees or sub-transfer agency fees, directors fees, legal fees, accounting fees and similar fees, to the extent consistent with past practice, subject to an annual cap of $30,000.
Term of the Sub-Advisory Agreement.If the Sub-Advisory Agreement is approved by shareholders of the Fund (and the Advisory Agreement is also approved by Shareholders), the Sub-Advisory Agreement will become effective with respect to the Fund immediately upon the final adjournment of the Meeting. The Sub-Advisory Agreement will remain in force for an initial term of two years, and from year to year thereafter, subject to annual approval by: (1) the Board of Directors, or (2) a vote of a majority (as defined in the Investment Company Act) of the outstanding shares of the Fund. In either event, continuance of the Sub-Advisory Agreement must also be approved by a majority of the Independent Directors, by a vote cast in person at a meeting called for the purpose of voting on the continuance.
Termination.The Sub-Advisory Agreement may be terminated at any time by the Adviser, the Board or the Sub-Adviser on at least sixty (60) days’ prior written notice. The Sub-Advisory Agreement will automatically terminate in the event of its assignment (as defined in the Investment Company Act). The Sub-Advisory Agreement will also terminate upon written notice to the other party that the other party is in material breach of the Sub-Advisory Agreement, unless the other party in material breach of the Sub-Advisory Agreement cures such breach to the reasonable satisfaction of the party alleging the breach within thirty (30) days after written notice.
The proposed Advisory Agreement is attached hereto asExhibit A and the proposed Sub-Advisory Agreement is attached hereto asExhibit B. The description of each such agreement set forth in this Proxy Statement is qualified in its entirety by reference toExhibit A andExhibit B.
Evaluation of the Advisory Agreement and Sub-Advisory Agreement by the Board of Directors
The Investment Company Act requires that the Board of Directors, including the Independent Directors, review the Fund’s advisory contracts and consider whether to approve them and recommend that shareholders of the Fund approve them. On April 12, 2019, the Board of Directors, including all Independent Directors, met to consider and discuss the retention of the Adviser as the investment adviser to the Fund and the engagement of DCM as sub-adviser to the Fund. As described in further detail below, the Board had previously made a detailed request for information from each of the Adviser and DCM in connection with the Board’s consideration of the approval of the Advisory Agreement and the Sub-Advisory Agreement, and the Adviser and Sub-Adviser each promptly responded to that request.
The materials provided by the Adviser contained information regarding: the nature, extent and quality of the services that the Adviser currently provides to the Fund; the investment performance of the Fund; the costs of the services that the Adviser provides to the Fund and that the Adviser can provide to the Fund; the extent to which economies of scale benefit the Fund’s shareholders; and the profits realized by the Adviser and its affiliates from its relationship with the Fund.
The materials provided by DCM contained information regarding: the nature, extent and quality of the services that DCM can provide to the Fund; the investment performance of the funds that DCM currently advises; the costs of the services that DCM would provide to the Fund; the extent to which DCM may help to realize economies of scale for the benefit of the Fund’s shareholders; and the profits that may be realized by DCM and its affiliates from its relationship with the Fund.
The Board of Directors, including all Independent Directors, conferred with representatives of the Adviser to evaluate the qualifications of the Adviser to continue to serve as, and associated considerations surrounding the advisability of retaining the Adviser as, investment adviser to the Fund. At an in-person meeting on April 12, 2019, the Directors, including all of the Independent Directors, unanimously approved the Advisory Agreement and unanimously recommended that the shareholders of the Fund vote in favor of the approval of the Advisory Agreement.
The Board of Directors, including all Independent Directors, also conferred with representatives of DCM to evaluate the qualifications of DCM to serve as, and associated considerations surrounding the advisability of retaining DCM as, sub-adviser to the Fund. At an in-person meeting on April 12, 2019, the Directors, including all of the Independent Directors, unanimously approved the Sub-Advisory Agreement and unanimously recommended that the shareholders of the Fund vote in favor of the approval of the Sub-Advisory Agreement.
In determining whether to approve each of the Advisory Agreement and the Sub-Advisory Agreement, the Directors considered the best interests of the Fund and its shareholders.
The Board's deliberations of the proposed relationships with CFSC, as Adviser, and DCM, as Sub-Adviser, are presented contemporaneously given the overlapping considerations, parallel issues, and conclusions drawn by the Board. The Board considered, among other things:
Nature, Extent and Quality of Services. With respect to the nature, extent and quality of services provided by CFSC, the Board reviewed CFSC’s most recent Form ADV, a description of the manner in which investment decisions are made for the Fund, a description of the services provided by CFSC, and evaluated the experience of professional personnel performing services for the Fund, including the team of individuals that primarily monitor and execute the investment and administration process. Similarly, to evaluate the nature, extent, and quality of services offered by DCM, the Board reviewed DCM’s most recent Form ADV, a description of the manner in which investment decisions would be made for the Fund, and a description of DCM’s services, and evaluated the experience of DCM’s professional personnel that would perform services for the Fund, including the team of individuals that would primarily monitor and execute the investment and administration process. The Board also obtained assurances that each of DCM and CFSC has adopted a Code of Ethics containing provisions reasonably necessary to prevent Access Persons, as that term is defined in Rule 17j-1 under the Investment Company Act, from engaging in conduct prohibited by Rule 17j-1(b), and that each has adopted procedures reasonably necessary to prevent Access Persons from violating such Codes of Ethics.
In reaching its conclusions, the Board considered that CFSC would delegate day-to-day investment decisions of the Fund to DCM and that CFSC would provide general management and oversight of DCM with respect to DCM’s activities as Sub-Adviser. The Board considered the services to be provided by CFSC, including an ongoing program of monitoring and oversight of DCM, regular compliance reviews of DCM and its investment management processes, trade execution, and other administrative services. The Board noted that CFSC appeared to be adequately carrying out its intended functions and that CFSC had not reported any material compliance matters. The Board concluded that CFSC had sufficient quality and depth of personnel, resources, investment methods and compliance policies and procedures essential to performing its duties under the Advisory Agreement and that the nature, overall quality, and extent of the management services provided by CFSC were satisfactory and reliable.
With respect to DCM, the Directors considered that DCM will have primary responsibility for the Fund's investment management. The Board reviewed the DCM team’s skills and experience and attended a presentation related to DCM's portfolio management and research techniques. The Board also considered that DCM's compliance policies and procedures appeared to be operating effectively, and that CFSC and DCM appeared to be communicating effectively. The Board concluded that DCM had sufficient quality and depth of personnel, resources, investment methods and compliance policies and procedures essential to performing its duties under the Sub-Advisory Agreement and that the nature, overall quality and extent of the management services that would be provided by DCM to the Fund will be satisfactory and reliable.
Performance. The Directors considered that CFSC will generally delegate its day-to-day investment decisions to DCM and that it will not directly manage the investment decisions of the Fund. However, CFSC will provide support to DCM in the execution of its investment strategy, including with respect to trade oversight, and reporting to the Board. The Board considered that CFSC will monitor DCM's adherence to the Fund's investment objectives, strategies and policies and supervise DCM’s other functions appropriately, including with respect to compliance and trade execution.
With respect to CFSC’s performance, the Board considered the performance of the Fund for the various periods ended December 31, 2018 as compared to the one-year, three-year, five-year, and since-inception periods. The Board also noted that over the long term, performance was generally favorable, although somewhat mixed across all comparative benchmarks. The Directors agreed that the Fund was performing as intended over the long term. Overall, the Directors concluded that performance was satisfactory.
Fees and Expenses. The Board considered the Fund's fee arrangement, under which the Fund pays CFSC an annual fee of 1% of the first $25 Million of average daily net securities assets, .75% of the next $15 Million of average daily net securities assets and .50% of the excess of net securities over $40 Million. They reviewed the advisory fees paid by similarly sized funds and found the Fund's fee to be competitive.
The Board also considered the allocation of the responsibilities as between CFSC and DCM, finding that DCM will be responsible for the management of the Fund's portfolio and that CFSC will provide oversight, administrative and support services to DCM, and determined that the allocation of 75% of the net management fee to DCM was reasonable in relation to the services rendered by each of CFSC and DCM. The Board then concluded that the advisory and sub-advisory fees were not unreasonable and that the overall expense ratio was acceptable in light of the factors considered.
Profitability. The Board also considered the historical and anticipated profitability of CFSC and the anticipated profitability of DCM and whether such profits were reasonable in light of the services provided to the Fund, and found that at current asset levels CFSC’s relationship with the Fund was slightly profitable, but not excessive.
With respect to DCM, the Board considered DCM’s anticipated costs for the provision of services to the Fund and found that DCM's anticipated levels of profitability from its relationship with the Fund were not excessive.
Economies of Scale. The Board considered whether CFSC and DCM would realize economies of scale with respect to their management of the Fund. The Board reviewed and considered the profitability analyses and selected financial information of each of CFSC and DCM and also took into account the current assets. The Board concluded that, at current asset levels, economies of scale were not achievable, but would be revisited as the Fund grows in assets.
Conclusion. Having requested and received such information from each of CFSC and DCM as the Board believed to be reasonably necessary to evaluate the terms of the Advisory Agreement and Sub-Advisory Agreement, respectively, and as assisted by the advice of counsel, the Board, including a majority of the Independent Directors, determined that approval of the Advisory Agreement and approval of the new Sub-Advisory Agreement for the Fund were in the best interests of the Fund and its current and future shareholders. Furthermore, the Board concluded the approvals would not result in an unfair burden to the Fund’s shareholders. No single factor was considered in isolation or to be determinative to the decision of the Directors to approve each of the Advisory Agreement and Sub-Advisory Agreement and recommend approval to the Fund’s shareholders and each Director may have attributed different weights to the various factors noted above. Rather, the Directors concluded, in light of their weighing and balancing all factors, that approval of each of the Advisory Agreement and the Sub-Advisory Agreement was in the best interests of the Fund and its shareholders.
Shareholder Approval
To become effective with respect to the Fund, the vote of a majority of the outstanding shares of the Fund is required for approval of each of the Advisory Agreement and Sub-Advisory Agreement. The vote of a majority of the outstanding shares of the Fund means the vote of the lesser of: (1) 67% or more of the shares of the Fund present or represented by proxy at the Meeting, if the holders of more than 50% of the outstanding shares of the Fund are present or represented by proxy, or (2) more than 50% of the outstanding shares of the Fund.For purposes of determining the approval of each of the Advisory Agreement and Sub-Advisory Agreement, abstentions and broker non-votes will have the same effect as shares voted against the Proposal.
The Board of Directors unanimously recommends that shareholders of the Fund vote FOR the Advisory Agreement.
The Board of Directors unanimously recommends that shareholders of the Fund vote FOR the Sub-Advisory Agreement.
| PROPOSAL 3: | TO ELECT THREE DIRECTOR NOMINEES TO SERVE ON THE BOARD OF DIRECTORS |
Background. The Board of Directors is currently comprised of the following three Directors: Mr. Gary S. Gaines, Mr. Roy G. Hale, and Mr. David I. Faust. Mr. Gaines and Mr. Hale are both Independent Directors (i.e., not “interested persons” as defined in the Investment Company Act). None of the Directors has been previously elected by the Fund’s shareholders. Mr. Gaines has been a Director of the Fund since he was appointed by the Fund’s then-current Board of Directors in 2009 and currently serves as the Lead Independent Director. Mr. Hale has served as a Director since he was appointed by the Fund’s then-current Board of Directors in 2011 and serves as the President and Treasurer of the Fund. Mr. Hale previously served as the auditor of the Fund from 1991 through 2008. Mr. Faust was appointed by the Fund’s then-current Board of Directors to serve as a Director in 2018 and he also serves as Secretary and Chief Compliance Officer of the Fund. Mr. Faust is a partner at the law firm Gallet Dreyer & Berkey, LLP and in this role serves as counsel to the Fund and the Adviser. Mr. Faust is also the controlling person of the Adviser as a result of his role as personal representative of the estate of Mr. Irving Levine, the sole owner of the Adviser. Mr. Faust is an interested Director due to his relationship with the Adviser.
The Directors have determined, in consultation with the Adviser, that the Fund would benefit from their continued service on the Board. You are being asked to vote on the election of the Nominees—Mr. Gaines, Mr. Hale, and Mr. Faust—to continue to serve on the Board. Upon their election as Directors by the Fund’s shareholders, Mr. Gaines and Mr. Hale will continue to serve as Independent Directors and Mr. Faust will continue as an interested Director.
The Directors of the Company are responsible for nominating, selecting and appointing directors to stand for election at appropriate meetings of the shareholders of the Company. The Board considered nomination of Directors at one meeting during the last fiscal year. Among the factors that the Directors generally consider are the candidate’s general understanding of the mutual fund industry; educational background; business and professional experience; interpersonal skills and ability to contribute to the ongoing functions of the Board; and any specific financial, technical or other expertise possessed by the candidate. While the Directors have not adopted a specific policy on diversity or a particular definition of diversity, when considering candidates, the Directors generally consider the manner in which each candidate’s experience, viewpoints and backgrounds are complementary to the existing Directors’ attributes. Due to the Board’s historical small size and low rate of turnover, the Board has not established a nominating committee, does not conduct its nominating functions pursuant to a formal charter, and does not have a formal policy regarding consideration of candidates recommended by shareholders. The Board recommended each of the Nominees.
On April 12, 2019, the Board met to review pertinent information on the respective nominations of Mr. Gaines, Mr. Hale, and Mr. Faust as Directors and nominated and selected them for election as Directors. The Board unanimously recommends that the shareholders vote in favor of the election of the Nominees.
Federal securities laws generally require that a majority of the members of a Fund’s board of directors be elected by shareholders. To ensure compliance federal securities law requirements, shareholders are being asked at this Meeting to elect the Nominees. None of the Nominees has previously been elected by shareholders. The term of office of each Nominee will be three (3) years, or until the next annual meeting of the Board, whichever occurs first, or until such Director retires, or until he/she dies, resigns, or is removed, whichever is sooner. Each Nominee has indicated a willingness to continue to serve as a Director if elected. If any of the Nominees should not be available for election, the persons named as proxies (or their substitutes) may vote for other persons in their discretion. However, management has no reason to believe that any Nominee will be unavailable for election.
Background and other information regarding the Directors, the Nominees and the Fund’s officers is set forth below.
The Board of Directors Generally
Section 3.2 of the Fund’s Amended and Restated Bylaws, as amended (“Bylaws”), authorizes the Directors to determine the number of Directors on the Board, and to increase or decrease the number of Directors to a number other than the number previously determined. The Bylaws state that the Board will consist of at least one (1) individual and not more than thirteen (13) individuals. As noted above, the Board currently consists of three Directors.
The Board oversees the management of the Fund and meets quarterly, or more frequently if necessary, to review reports about the Fund’s operations. The Board provides broad supervision over the affairs of the Fund and appoints the officers of the Fund to actively supervise the Fund’s day-to-day operations. Subject to the Investment Company Act and applicable Nevada law, the Board may fill vacancies in the Board and may increase or reduce the number of Board members as it deems appropriate. The Board may also appoint from their own number and establish (and terminate) committees, which may exercise the powers and authority of the Board to the extent that the Board determines. The Board may, in general, delegate such authority as it considers desirable to any committee, except those which by law or by the Bylaws may not be delegated. Except as the Board may otherwise determine, any such committee may make rules for the conduct of its business, but unless otherwise provided by Board or in such rules, its business shall be conducted so far as possible in the same manner as is provided by the Bylaws for the Board itself.
Each Director serves as a Director for a term of three (3) years or until the next annual meeting of the Board, whichever occurs first, or until such Director retires, or until he/she dies, resigns, or is removed, whichever is sooner. The Board may elect successor Directors and may appoint Directors to fill vacancies, subject to the shareholder election requirements of the Investment Company Act (i.e., immediately after filling a vacancy, at least two-thirds of the Directors then holding office shall have been elected to such office by the Fund’s shareholders at an annual or special meeting). Such appointment or election shall be effective upon the acceptance of the person named therein to serve as a Director.
Subject to and except as otherwise provided in the Securities Act of 1933, as amended, and the Investment Company Act, Directors and officers of the Fund and certain of their affiliates are entitled to indemnification for certain matters related to their roles with the Fund, provided that such person either is not liable pursuant to Nevada Revised Statutes 78.138 or acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Fund and, with regards to criminal conduct, had no reasonable cause to believe that his or her conduct was unlawful.
Information Regarding the Nominees and Officers of the Fund.
The Board has considered each Nominee’s experience, qualifications, attributes and skills in light of the Board’s function and the Fund’s business and structure, and has determined that each Nominee possesses experience, qualifications, attributes and skills that will enable the Nominee to continue to be an effective member of the Board. Set forth in the table below is a summary of the specific experience, qualifications, attributes and/or skills for each Nominee. The Board has determined that each of the Nominees’ careers and background, combined with their interpersonal skills and general understanding of financial and other matters, will enable the Nominees to continue to effectively participate in and contribute to the Board’s functions and oversight of the Fund. References to the qualifications, attributes and skills of Nominees are pursuant to requirements of the U.S. Securities and Exchange Commission (“SEC”), do not constitute holding out the Board or any Nominee as having any special expertise or experience, and shall not impose any greater responsibility on any such person or on the Board by reason thereof.
Mr. Gary S. Gaines
Mr. Gaines has been a Director of the Fund since 2009. He received a B.A. degree from Harvard College in 1958 and attended the University of Florence (Italy) in 1958 and 1959 on a Fulbright Scholarship. He has been actively engaged as a retailer and manufacturer in the luggage, handbag and related products business since 1962. Mr. Gaines has been the President of Gary Gaines, Inc., a bag manufacturing company, since 1965. He has extensive experience as a successful private investor.
Mr. Roy G. Hale
Mr. Hale has been a director for the Fund since 2011. He is retired. He was previously the mayor of La Plata, Maryland and the principal of Roy G. Hale, CPA, a sole proprietorship which served as the auditor of the Fund from 1991 through 2008. He received a B.S. degree from University of Maryland in 1977. Mr. Hale previously served as a Director of the Bank of Southern Maryland from 1999 to 2013. Mr. Hale has been a Certified Public Accountant since 1979.
Mr. David I. Faust
Mr. Faust has been a director for both the Fund and the Adviser since 2018. Mr. Faust also serves as the Chief Compliance Officer and Secretary of the Fund. Outside of his service to the Fund, Mr. Faust has been a partner with the law firm Gallet Dreyer & Berkey, LLP since 2016, and prior to that, Mr. Faust was a partner with the law firm Faust Oppenheim LLP. In his role as a partner at Gallet Dreyer & Berkey, LLP, Mr. Faust serves as counsel to the Fund and the Adviser. Gallet Dreyer & Berkey, LLP is paid a fixed monthly fee by the Fund for its services and the Adviser pays fees at customarily hourly rates. Mr. Faust is also the controlling person of the Adviser as a result of his role as personal representative of the estate of Mr. Irving Levine, the sole owner of the Adviser.
Following is a list of the Nominees/Directors, as well as the officers of the Fund. The business address of each Director, Nominee and officer is 5348 Vegas Drive, Suite 391, Las Vegas, NV 89108.
Name, (Age) and Position(s) Held with Fund | Term of Office and Length of Time Served | Principal Occupation(s) During Past Five Years | Number of Funds in Fund Complex Overseen by Director | Other Directorships Held by Director During the Past 5 Years |
INDEPENDENT DIRECTORS |
Gary S. Gaines (78) Lead Independent Director | Indefinite Term, Since 2009 | President of Gary Gaines, Inc., a bag manufacturing company, since 1965. | One | None |
Roy G. Hale (79) Independent Director, President and Treasurer | Indefinite Term, Since 2011 | Retired; Mayor of La Plata, MD from 2009 to 2017; CPA with Roy G. Hale, CPA from 1979 to 2015. | One | None |
Name, (Age) and Position(s) Held with Fund | Term of Office and Length of Time Served | Principal Occupation(s) During Past Five Years | Number of Funds in Fund Complex Overseen by Director | Other Directorships Held by Director During the Past 5 Years |
INTERESTED DIRECTOR |
David I. Faust* (78) Director, Chief Compliance Officer and Secretary | Indefinite Term, Director Since 2018, Secretary since 2016, CCO since 2010 | Partner – Gallet Dreyer & Berkey, LLP, a law firm, since October 2016; prior thereto, a partner at Faust Oppenheim LLP. | One | None |
OFFICERS WHO ARE NOT DIRECTORS |
Adam Berkey (30) Assistant Secretary | Indefinite Term, Since 2019 | Attorney at Gallet Dreyer & Berkey, LLP. | N/A | N/A |
| * | Mr. Faust is an interested Director as a result of his relationship with the Adviser. |
Compensation
The fees for Independent Directors, $6,000 per year and $250 for each Board and informal audit committee meeting attended in person or by telephone, are paid by the Fund. The Directors also are reimbursed for expenses related to meetings. No Interested Director or officer receives direct compensation from the Fund. In his role as a partner at Gallet Dreyer & Berkey, LLP, Mr. Faust serves as counsel to the Fund and the Adviser. Gallet Dreyer & Berkey, LLP is paid a fixed monthly fee by the Fund for its services and the Adviser pays fees at customarily hourly rates. During the Fund’s fiscal year ended February 28, 2019 the Fund paid Gallet Dreyer & Berkey, LLP, the law firm at which Mr. Faust, the control person of the Adviser, is a partner, fees in the aggregate amount of approximately $120,000.00 for legal services.
For the fiscal year ended February 29, 2019, the Directors received the following compensation from the Fund:
Director | Aggregate Compensation from Fund | Pension or Retirement Benefits Accrued As Part of Fund Expenses | Estimated Annual Benefits Upon Retirement | Total Compensation from Fund & Fund Complex |
Interested Director |
Irving Levine* | $0 | $0 | $0 | $0 |
David I. Faust | $0 | $0 | $0 | $0 |
Independent Directors |
Gary S. Gaines | $6,250 | $0 | $0 | $0 |
Roy G. Hale | $10,600 | $0 | $0 | $0 |
| * | Mr. Levine was an interested Director until his death on May 5, 2018. |
Information Concerning Fund Committees
Due to the small size of the Board of Directors, the Board has not established any formal, standing committees. However, the Independent Directors meet two times during the fiscal year to function as an informal audit committee. As such, they review the audits of the Fund and recommend a firm to serve as independent registered public accounting firm of the Fund. The Independent Directors also meet two times during the fiscal year to function as an informal valuation committee.
Board Leadership Structure
The Board has appointed Gary G. Gaines to serve as Lead Independent Director. The Lead Independent Director, among other things, chairs executive sessions of the Independent Directors, serves as a spokesperson for the Independent Directors and serves as a liaison between the Fund’s other Independent Directors and the Fund’s management, Chief Compliance Officer, service providers, auditors and counsel between Board meetings. The Fund believes this structure allows all of the Independent Directors to participate in the full range of the Board's responsibilities with respect to its oversight of the Fund's management. The Board has determined that this leadership structure, including the role of the Lead Independent Director, is appropriate given the size and complexity of the Fund, the number of Directors overseeing the Fund and the Board's oversight responsibilities.
The Board generally holds four regular meetings each year to consider and address matters involving the Fund. The Board also may hold special meetings to address matters arising between regular meetings. These meetings may take place in person or by telephone. The Independent Directors also meet each quarter and additionally on an as-needed basis in executive sessions outside the presence of management. The Board, including the Independent Directors, has access to legal counsel for the Fund for consultation concerning any issues that may occur during or between regularly scheduled Board meetings. As discussed below, the Board acts as an informal audit committee and valuation committee in performing its oversight responsibilities.
Qualifications of Directors
Among the attributes or skills common to all Directors (and, therefore, each Director) are their ability to critically review, evaluate, question and discuss information provided to them, to interact effectively with the other Directors, Fund management, the Fund’s investment adviser, other service providers, counsel and independent registered public accounting firm, and to exercise effective and independent business judgment in the performance of their duties as Directors. Each Director’s (and, therefore, each Nominee’s) ability to perform his duties effectively has been attained through the individual’s business, consulting, public service, professional and/or academic positions, and, because each Nominee is currently a Director, through experience from service as a board member of the Fund, and through experience from service as a board member of other registered investment companies, public companies, and/or non-profit entities or other organizations. Each Director's (and, therefore, each Nominee’s) ability to perform his duties effectively also has been enhanced by his educational background, professional training, and/or other life experiences. The specific experience, qualifications, attributes and/or skills that led to the conclusion that a Director (and, therefore, a Nominee) should serve as a Director of the Fund are as set forth in the tables above.
The Board has determined that each Director’s (and, therefore, each Nominee’s) careers and background, combined with their interpersonal skills and general understanding of financial and other matters, enable the Directors (and, therefore, the Nominees) to effectively participate and contribute to the Board’s functions in the oversight of the Fund.
Information Regarding Directors’ Attendance at Board Meetings
During the calendar year ended December 31, 2018, the Board held two regularly scheduled meetings and no special meetings. Each of the Directors attended all of the Board Meetings.
Nominee and Director Ownership of Fund Shares
The following table shows each Nominee’s beneficial ownership of shares of the Fund, stated as one of the following ranges: $0; $1 - $10,000; $10,001 - $50,000; $50,001 - $100,000; and Over $100,000. Information is provided as of June 12, 2019:
Director | Dollar Range of Equity Securities in the Fund |
Interested Director | |
David I. Faust | Over $100,000.00 |
Independent Directors | |
Gary S. Gaines | 0 |
Roy G. Hale, CPA | 0 |
Independent Directors Nominees' Ownership of Interests in, or other Business Relationships with, the Fund’s Adviser, Sub-Adviser or Principal Underwriter
As of [ ], 2019, no current Independent Director or Independent Director Nominee, nor any of his immediate family members, had any ownership position in the Adviser, the Sub-Adviser, or the Distributor, or any person (other than a registered investment company) directly or indirectly controlling, controlled by, or under common control with the Adviser, the Sub-Adviser or the Distributor.
No Independent Director or Independent Director Nominee purchased or sold securities of the Adviser, Sub-Adviser or either of their affiliates since the beginning of the Fund’s most recently completed fiscal year.
Shareholder Approval
The election of a Nominee requires the affirmative vote of the holders of a majority of shares represented in person or by proxy and entitled to vote on that matter.
The Board of Directors unanimously recommends that shareholders of the Fund vote FOR each Nominee.
| PROPOSAL 4: | TO RATIFY THE APPOINTMENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FUND |
The Board intends to appoint EisnerAmper LLP as the independent registered public accounting firm of the Fund for the fiscal year to end February 28, 2020. EisnerAmper LLP has served as independent registered public accounting firm of the Fund since 2010.
The Fund is asking shareholders to ratify the appointment by the Board of EisnerAmper LLP as the independent registered public accounting firm for the Fund for the fiscal year ending February 29, 2020 as a matter of good corporate governance. Neither the Fund’s Articles of Organization nor its Bylaws require that shareholders ratify the appointment of EisnerAmper LLP as the Fund’s independent registered public accounting firm. If the shareholders do not ratify the appointment, the Board will reconsider whether or not to appoint EisnerAmper LLP, but may nonetheless appoint such firm. Even if the appointment is ratified, the Board, in its discretion, may change the appointment at any time during the year if it determines that such change would be in the best interest of the Fund and its shareholders. The Board will determine what action to take with respect to appointing an independent registered public accounting firm for the Fund for future years.
Representatives of EisnerAmper LLP are not expected to attend the Meeting or be available to respond to questions. However, EisnerAmper LLP will have an opportunity to make a statement if it desires to do so.
The Board unanimously recommends that you vote “FOR” the ratification of EisnerAmper LLP as the Fund’s independent registered public accounting firm for the fiscal year to end February 29, 2020.
Audit Fees
Below is information relating to fees billed for professional audit services rendered by EisnerAmper LLP for the audit of the Fund’s annual financial statements for the past two fiscal years and for fees billed for other services rendered by EisnerAmper LLP to the Fund:
Type of Fee | Fiscal Year Ended February 28, 2019 | Fiscal Year Ended February 28, 2018 |
Audit Fees: | | |
•Audit Fee | $35,000 | $30,000 |
•Consent | $3,500 | $3,000 |
•Read and Comment on Semi-Annual Financial Statement | $12,500 | $12,000 |
Total Audit Related Fees: | $51,000 | $45,000 |
Tax Fees | | |
•Tax preparation | $18,500 | $10,000 |
•2015-2017 Massachusetts Corporate Tax Returns | $15,000 | - |
•Accumulated earning project | $5,500 | - |
Total Tax Fees | $39,000 | $10,000 |
Total | $90,000 | $55,000 |
The Board has not established formal pre-approval procedures and generally reconvenes on an informal basis to consider and approve any services outside the scope of the initial engagement of the Auditor.
In approving the selection of the Auditor for the Fund, the Board considered, in addition to other practices and requirements relating to the selection of the Fund’s independent registered public accounting firm, whether any services performed by the Auditor for the Fund, the Adviser and for certain related parties for which the Auditor received non-audit fees are compatible with maintaining the independence of the Auditor as the Fund’s independent registered public accounting firm.
| PROPOSAL 5: | TO TRANSACT ANY OTHER BUSINESS THAT MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF IN THE DISCRETION OF THE PROXIES OR THEIR SUBSTITUTES |
The proxy holders have no present intention of bringing any other matter before the Meeting other than those specifically referred to above or matters in connection with or for the purpose of effecting the same. Neither the proxy holders nor the Board of Directors are aware of any matters which may be presented by others. If any other business shall properly come before the Meeting, the proxy holders intend to vote thereon in accordance with their best judgment.
ADDITIONAL INFORMATION REGARDING SHAREHOLDERS AND VOTING REQUIREMENTS
Record Date. The Board of Directors has fixed the close of business on [Record Date], 2019 (the “Record Date”), as the record date for the determination of shareholders of the Fund entitled to notice of and to vote at the Meeting or any adjournment thereof. As of the Record Date, there were [__________] shares of beneficial interest of the Fund outstanding.
All full shares of the Fund are entitled to one vote, with proportionate voting for fractional shares.
On the Record Date, all Directors and officers of the Fund as a group owned of record or beneficially [____%] of the outstanding shares of the Fund.
5% Shareholders. As of the Record Date, the following shareholders owned of record more than 5% of the outstanding shares of beneficial interest of the Fund. No other person owned of record and, according to information available to the Fund, no other person owned beneficially, 5% or more of the outstanding shares of the Fund on the Record Date:
Name and Address of Beneficial Owner | Number of Shares | Percent of Class |
| | |
| | |
| | |
| | |
Quorum.A quorum is the number of shares legally required to be at a meeting in order to conduct business. The presence, in person or by proxy, of more than 50% of the outstanding shares of the Fund is necessary to constitute a quorum at the Meeting. Proxies properly executed and marked with a negative vote or an abstention will be considered to be present at the Meeting for purposes of determining the existence of a quorum for the transaction of business. If the Meeting is called to order but a quorum is not present at the Meeting, the persons named as proxies may vote those proxies that have been received to adjourn the Meeting to a later date. If a quorum is present at the Meeting but sufficient votes to approve a Proposal described herein are not received, the persons named as proxies may propose one or more adjournments of the Meeting to permit further solicitation of proxies. Any such adjournment will require the affirmative vote of a majority of those shares represented at the Meeting in person or by proxy. The persons named as proxies will vote those proxies received that voted in favor of a Proposal in favor of such an adjournment and will vote those proxies received that voted against the Proposal against any such adjournment.
Abstentions and “broker non-voters” are counted for purposes of determining whether a quorum is present but do not represent votes cast with respect to a Proposal. “Broker non-votes” are shares held by a broker or nominee for which an executed proxy is received by the Fund, but are not voted as to one or more Proposals because instructions have not been received from the beneficial owners or persons entitled to vote and the broker or nominee does not have discretionary voting power. Notwithstanding the foregoing, “broker non-votes” will be excluded from the denominator of the calculation of the number of votes required to approve any Proposal to adjourn the Meeting. Accordingly,abstentions and “broker non-votes” will effectively be a vote against a Proposal, for which the required vote is a percentage of the outstanding voting shares and will have no effect on a vote for adjournment.
ADDITIONAL INFORMATION REGARDING THE OPERATION OF THE FUND
Investment Adviser
CFSC is 100% owned by the estate of Irving Levine. The estate of Mr. Levine is controlled by Mr. David I. Faust, 845 Third Avenue, 5th Floor, New York, NY 10022-6601. Mr. Faust is also a director of CFSC and the principal executive officer of CFSC. Mr. Faust’s principal occupation is attorney at Gallet Dreyer & Berkey, LLP. Mr. Faust also serves as Director, Chief Compliance Officer and Secretary of the Fund. No other officer or Director of the Fund is an officer, employee, director, general partner or shareholder of CFSC.
Proposed Sub-Adviser
DCM Advisors, LLC was founded in 2001 and is a Delaware limited liability company having a principal office at 475 Park Avenue South, 9th Floor, New York, New York. DCM is a registered investment adviser with the SEC.
DCM is a wholly-owned subsidiary of Dinosaur Group Holdings, LLC, a Delaware limited liability company (“DGH”). The managing member and majority owner of DGH is Glenn A. Grossman. Mr. Grossman’s principal occupation is Chief Executive Officer of DGH. The address for DGH and Mr. Grossman is 470 Park Avenue South, 9th Floor, New York, NY 10016. Marc Rappaport is the CEO of DCM. DCM is affiliated with the following entities which are also wholly-owned subsidiaries of DGH: (i) Dinosaur Financial Group, LLC, an SEC registered broker-dealer and is a member of the Financial Industry Regulatory Authority, Inc. (FINRA); (ii) Dinosaur Merchant Bank Limited, a UK registered broker-dealer; and (iii) Atlantic Trading and Technical Services, LLC, a technology service provider. In addition, DCM is affiliated with, through DGH’s 48% ownership in, Lisanti Capital Growth, LLC, an SEC registered investment adviser and investment adviser to the Lisanti Small Cap Growth Fund, a series of the Forum Funds, a registered open-end investment company.
The name, address and principal occupation of the principal executive officer and each director of DCM is as follows:
Marc Rappaport, 470 Park Avenue South, 9th Floor, New York, NY 10016. Mr. Rappaport’s principal occupation is CEO of DCM.
Portfolio Manager: Dr. Vijay Chopra has over 25 years’ experience in the investment advisory business. He is currently a Senior Portfolio Manager in the Global and International Equity Group at DCM, which manages several portfolio strategies, primarily though separately managed accounts. Dr. Chopra is also a Vice President at CFSC and has served as portfolio manager of the Fund in that role since April 1, 2019. It is anticipated that Dr. Chopra will continue to serve as the portfolio manager of the Fund following shareholder approval of the Sub-Advisory Agreement. Additionally, Dr. Chopra serves as the Portfolio Manager of Centaur Total Return Fund, a registered open-end investment company. Previously, Dr. Chopra managed equity strategies at Lebenthal Asset Management, Roosevelt Investments, Mesirow Financial and Bear Stearns Asset Management. He also has served as portfolio manager with Jacobs Levy Management, Deutsche Asset Management, State Street Global Advisors and Bankers Trust Company, and senior Research Analyst with Frank Russell Company. Dr. Chopra received a degree in electrical engineering from the Indian Institute of Technology. He also received his MBA and PhD in Finance from Vanderbilt University.
DCM currently serves as the investment adviser to the of Centaur Total Return Fund, a registered open end investment company, with a similar investment objective to the Fund. As of March 29, 2019 the Centaur Total Return Fund had a total of $11,730,512 in assets. As full compensation for the investment advisory services provided to the Centaur Total Return Fund, DCM receives monthly compensation based on the Centaur Total Return Fund’s average daily net assets at the annual rate of 0.75%. DCM has entered into an Expense Limitation Agreement with the Centaur Total Return Fund effective March 7, 2019 under which it has agreed to reduce the amount of the investment advisory fees to be paid to DCM by the Centaur Total Return Fund and assume other expenses of the Centaur Total Return Fund, if necessary, in an amount that limits “Total Annual Fund Operating Expenses” (exclusive of interest, taxes, brokerage commissions, other expenditures which are capitalized in accordance with generally accepted accounting principles, other extraordinary expenses not incurred in the ordinary course of the Centaur Total Return Fund’s business, dividend expense on securities sold short, “acquired fund fees and expenses,” and amounts, if any, payable pursuant to a plan adopted in accordance with Rule 12b-1 under the Investment Company Act) to not more than 1.50% of the average daily net assets of the Centaur Total Return Fund for the period ending February 28, 2021.
No officer or Director of the Fund is also an officer, employee or shareholder of the Sub-Adviser.
Principal Underwriter
Ultimus Fund Distributors, LLC (the “Distributor”), whose principal address is 225 Pictoria Drive, Suite 450, Cincinnati, OH 45246, is the distributor (also known as principal underwriter) of the shares of the Fund. The Distributor is a registered broker-dealer and is a member of FINRA.
Under a Distribution Agreement with the Fund, dated [______], 2019, the Distributor acts as the agent of the Fund in connection with the continuous offering of shares of the Fund. The Distributor continually distributes shares of the Fund on a best efforts basis. The Distributor has no obligation to sell any specific quantity of Fund shares. The Distributor and its officers have no role in determining the investment policies or which securities are to be purchased or sold by the Fund. The Distributor is paid a fee of $8,000 per year, the costs of which will be shared by the Adviser and the Sub-Adviser, for certain distribution-related services.
The Distributor may enter into agreements with selected broker-dealers, banks or other financial intermediaries for distribution of shares of the Fund. With respect to certain financial intermediaries and related fund “supermarket” platform arrangements, the Fund and/or the Adviser or Sub-Adviser, rather than the Distributor, typically enter into such agreements. These financial intermediaries may charge a fee for their services and may receive shareholder service or other fees from parties other than the Distributor. These financial intermediaries may otherwise act as processing agents and are responsible for promptly transmitting purchase, redemption and other requests to the Fund.
Administration, Fund Accounting, Transfer Agency and Other Services
Gemini Fund Services, LLC, whose principal address is 17605 Wright St., Omaha, NC 68130, serves as administrator to the Fund (the “Administrator”).
Pursuant to an agreement between the Administrator and the Fund, the Administrator has agreed to provide certain fund accounting and services to the Fund, including among other services, accounting relating to the Fund and its investment transactions; computing daily net asset values; semi-annual and annual shareholder reports; assisting in the preparation of registration statements and other filings related to the registration of shares; preparing and maintaining the Fund's books of account, records of securities transactions, and all other books and records in accordance with applicable laws, rules and regulations (including, but not limited to, those records required to be kept pursuant to the Investment Company Act); and performing such other duties related to the administration of the Fund as may be agreed upon in writing by the parties to the respective agreements
Compensation for the services and facilities provided by the Administrator under its administration agreement with the Fund includes payment of the Administrator's out-of-pocket expenses. The Administrator's reimbursable out- of-pocket expenses include, but are not limited to, postage and mailing, telephone, telex, Federal Express, independent pricing service charges, and record retention/storage.
Annual and Semiannual Reports
The Fund will furnish, without charge, a copy of its most recent annual report and most recent semi-annual report succeeding such annual report, if any, upon request. To request the annual or semi-annual report, please call us toll free at 1-877-881-2751 or write Copley Fund, Inc. at c/o Gemini Fund Services, LLC, 17605 Wright St., Omaha, NE 68130.
OTHER MATTERS
Shareholder Proposals
The Fund does not intend to, and is not required to hold annual meetings of shareholders, except under certain limited circumstances. The Board of Directors does not believe a formal process for shareholders to send communications to the Board of Directors is appropriate due to the infrequency of shareholder communications to the Board of Directors. The Fund has not received any shareholder proposals to be considered for presentation at the Meeting. Under the proxy rules of the SEC, shareholder proposals may, under certain conditions, be included in the Fund’s proxy statement and proxy for a particular meeting. Under these rules, proposals submitted for inclusion in the Fund’s proxy materials must be received by the Fund within a reasonable time before the solicitation is made. The fact that the Fund receives a shareholder proposal in a timely manner does not insure its inclusion in its proxy materials, because there are other requirements in the proxy rules relating to such inclusion. Annual meetings of shareholders of the Fund are not required as long as there is no particular requirement under the Investment Company Act, which must be met by convening such a shareholder meeting. Any shareholder proposal should be sent to David Faust, Secretary, Copley Fund, Inc. at c/o Gemini Fund Services, LLC, 17605 Wright St., Omaha, NE 68130.
Board Meetings During the Most Recent Fiscal Year
The Board held two meetings during the most recent fiscal year.
Shareholder Communications with Directors
Shareholders who wish to communicate with the Board or individual Directors should write to the Board or the particular Director, care of the Fund, at the offices of the Fund as set forth below. All communications will be forwarded directly to the Board or the individual Director.
Shareholders also have an opportunity to communicate with the Board at shareholder meetings. The Fund does not have a policy requiring Directors to attend shareholder meetings. The Directors do not intend to attend the Meeting
Proxy Delivery
The Fund may only send one Proxy Statement to shareholders who share the same address unless the Fund has received different instructions from one or more of the shareholders. The Fund will deliver promptly to a shareholder, upon oral or written request, a separate copy of the Proxy Statement to a shared address to which a single copy of this Proxy was delivered. By calling or writing the Fund, a shareholder may request separate copies of future proxy statements, or if the shareholder is receiving multiple copies of the proxy statement now, may request a single copy in the future. To request a paper or email copy of the Proxy Statement or annual report at no charge, or to make any of the aforementioned requests, call us toll free at 1-877-881-2751 or write to Copley Fund, Inc. at c/o Gemini Fund Services, LLC, 17605 Wright St., Omaha, NE 68130.
| By Order of the Board of Directors, |
| |
| David Faust, Secretary, Copley Fund, Inc. |
Date: [___________], 2019
Please complete, date and sign the enclosed Proxy and return it promptly in the enclosed reply envelope. NO POSTAGE IS REQUIRED IF MAILED IN THE UNITED STATES. You may also vote by telephone or through the internet by following the instructions on your proxy card.
Exhibit A
PROPOSED INVESTMENT ADVISORY AGREEMENT
BY AND BETWEEN
THE FUND AND THE ADVISER
INVESTMENT ADVISORY AGREEMENT
THIS INVESTMENT ADVISORY AGREEMENT, made as of the ___th day of August, 2019 (the “Effective Date”), by and between COPLEY FUND, INC., a Nevada corporation, (hereinafter called the “Fund”); and COPLEY FINANCIAL SERVICES CORP., a Massachusetts corporation (hereinafter called the “Advisor”).
WHEREAS, the Fund has been organized as an investment company, and desires to employ its capital by investing and reinvesting the same in securities of the type and in accordance with the limitations specified it its effective prospectuses in such manner as may be approved from time to time by its Board of Directors; and
WHEREAS, the Fund desires to avail itself of the experience, sources of information, advice, assistance and certain facilities available to the Advisor and to have the Advisor perform for it various advisory, statistical, accounting and clerical services; and
WHEREAS, the Advisor is willing to furnish such advice, facilities, and services on the terms and conditions hereinafter set forth;
NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained, it is agreed as follows:
| 1) | The Advisor, subject to the direction of the Board of Directors of the Fund, shall provide the Fund with investment research and advice and shall manage and supervise the Fund’s portfolio of investments. In performing this function, the Advisor shall furnish the securities in the Fund’s portfolio and proposed additions to the portfolio as the Advisor deems appropriate or as the directors of the Fund may reasonably request. The Advisor shall supervise the Fund’s relations with its Transfer Agent, Custodian, auditors, and the federal and state regulatory bodies and shall furnish office space and secretarial and clerical assistance necessary for each of the foregoing functions. |
| 2) | It is understood and agreed that the Fund shall pay all of its ordinary expenses of operation unless specifically excepted, such expenses of operation include but are not limited to the following: (i) the expense of maintaining its own books of account; (ii) the expense of maintaining one or more of its Custodians, Transfer Agents, Registrars and Dividend Disbursing Agents; (iii) the expenses of computing the net asset value of shares of the Fund; (iv) the fees and expenses of its directors, including those directors who may be directors of the Advisor, or any subsidiary corporation; (v) the expenses of meetings of its shareholders; (vi) the expenses of printing and mailing of all stockholder reports and other required reports and documents provided shareholders; (vii) taxes of any kind assessed against the Fund; (viii) interest and commissions; (ix) Securities and Exchange Commission registration fees; (x) state registration fees; (xi) the expenses of corporate existence, including the salary of a corporate secretary; (xii) the fees of its auditors; (xiii) the fees of its legal counsel; and (xiv) all other ordinary expenses of operation. The Fund also shall pay all extraordinary expenses of whatever kind of nature, unless such expenses have been specifically assumed by the Advisor or one of its affiliates. |
| 3) | Subject to appropriate resolution of the Board of Directors, including the affirmative vote of a majority of the directors who are not interested persons of the fund, as defined in Section 2(a) (19) of the Investment Company Act of 1940 (the “ACT”), the Fund shall pay a specified portion of the total salaries of its officers or employees who perform the duties enumerated in subparagraph (b) of this paragraph, determined by reference to the duties actually performed for the Fund by the officers or employees as a proportion of the total duties actually performed by such officers and employees for other investment companies and for the Advisor and any subsidiary or affiliated corporation. It is agreed that such officers and employees may also be officers and employees of the Advisor and may be compensated by the Advisor for services performed for the Advisor. |
| 4) | As compensation for its services as investment advisor, the Fund agrees to pay Advisor an annual investment advisory fee (the “Advisory Fee”), computed as follows: |
| a. | 1.00% of the first $25,000,000 of average daily net assets; |
| b. | .75% of the next $15,000,000 of average daily net assets; and |
| c. | .50% of the average daily net assets in excess of $40,000,000. |
| 5) | The Advisory Fee will be paid monthly at the end of each calendar month. (b) For purposes of subparagraph 2(a) hereof, “average daily net assets” shall be determined by: (x) first taking the daily total value of the Fund’s assets and deducting therefrom the daily total liabilities of the Fund (the difference being hereinafter referred to as the “daily net assets”); and (y) at the end of each calendar month dividing the aggregate daily net assets of the Fund for the month just concluded by the number of days in such month. |
| 6) | The Advisor is authorized and directed in its discretion to allocate brokerage commissions on portfolio transactions for the Fund among such brokers and/or dealers who provide investment information, provide services to the Fund and other investment companies, collectively; provided, however, that such broker or dealers render satisfactory service at competitive commission rates, and subject, in any event, to the Fund obtaining the most favorable prices and executions of orders. |
| 7) | It is understood and agreed that the Advisor may act as investment Advisor to one or more other investment companies. If, while so acting, it appears that the purchases or sale of securities of the same issuer is advantageous to the Fund and such other investment companies and is consistent with the investment objectives of the Fund and such other companies and, if such purchases or sales should be executed at approximately the same time, each will be executed on a proportionate basis, if feasible or, in the alternative, on a rotating or other equitable bases. |
| 8) | The Advisor assumes no responsibility under this agreement other than to render the services called for hereunder in good faith, and shall not be responsible for any action of the Board of Directors of the Fund in following or declining to follow any advice or recommendations of the Advisor. The Advisor shall not be liable for any error of judgment or mistake of law or for any loss suffered by the Fund in connection with matters to which this agreement relates, except for a loss resulting from Advisor’s willful misfeasance, bad faith or gross negligence or a loss occasioned by the reckless disregard of Advisor’s obligations and duties under this agreement. |
| 9) | Nothing in this agreement shall limit or restrict the right of any director, officer or employee of the Advisor who may also be a director, officer or employee of the Fund to engage in any other business or to devote his time and attention in part to the management or other aspects of any other business, whether of a similar or dissimilar nature, nor limit or restrict the right of the Advisor to engage in any other business or to render services of any kind to any other corporation, firm, individual or association. Directors, officers and employees of the Fund are, therefore, specifically permitted to serve from time to time as directors, officers and employees of other corporations including the Advisor and subsidiaries, other companies which it may require, or with which it may merge or consolidate and other investment companies which the Advisor may organize or sponsor. |
| 10) | This agreement shall terminate automatically in the event of its assignment. This agreement may be terminated at any time, without the payment of any penalty by: (a) the Board of Directors of the Fund; (b) the vote of the holders of a majority of the outstanding voting securities of the Fund (as defined in Section 2(a) (42) of the Act); (c) upon sixty days’ written notice addressed to the Advisor at its principal place of business. |
| 11) | This agreement shall remain in effect for a period of one year from the Effective Date and shall continue in effect thereafter only so long as it is specifically approved annually by the Board of Directors, or by the vote of the holders of a majority of the outstanding voting securities of the Fund (as defined in Section 2(a) (42) of the Act) and, in either case, by the vote of a majority of the directors who are not parties to the agreement or interested persons (as defined in Section 2(a) (19) of the Act), of any such party, cast in person at a meeting called for the purpose of voting on such approval. |
IN WITNESS WHEREOF, the parties hereto have caused this agreement to be executed by their officers thereunto duly authorized:
| COPLEY FUND, INC. |
| | | |
| | |
| By: | | |
| Title: | | |
| | | |
| COPLEY FINANCIAL SERVICES CORP. |
| | | |
| | |
| By: | | |
| Title: | | |
Exhibit B
PROPOSED SUB-ADVISORY AGREEMENT
BY AND BETWEEN
THE FUND, THE ADVISER AND THE SUB-ADVISER
SUB-ADVISORY AGREEMENT
SUB-ADVISORY AGREEMENT (the “Agreement”), dated as of July ___, 2019, by and amongCopley Financial Services Corp.,a Massachusetts corporation (the “Adviser”),DCM Advisors, LLC, a Delaware limited liability company (the “Sub-Adviser”), and theCopley Fund, Inc., a Nevada corporation (the “Fund”).
WHEREAS, the Adviser is registered as an investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), and acts as the investment adviser for the Fund;
WHEREAS, the Adviser warrants and represents to the Sub-Adviser that the Adviser has full legal authority to engage unaffiliated investment managers to advise the Adviser and assist it in the management of the Fund;
WHEREAS, the Sub-Adviser is registered with the Securities and Exchange Commission (the “SEC”) as an investment adviser under the Advisers Act;
WHEREAS, the Fund is an open-end management investment company registered under the Investment Company Act of 1940, as amended (the “1940 Act”);
WHEREAS, the Adviser desires to retain the Sub-Adviser to render investment advisory services to the Adviser and the Sub-Adviser is willing to render such services; and
WHEREAS, this Agreement will not be effective until approved by the board of directors of the Fund (the “Board”) and the shareholders of the Fund;
NOW, THEREFORE, in consideration of the foregoing premises, the mutual agreements hereinafter set forth and for other good and valuable consideration, receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
1.Appointment and Status of Sub-Adviser. The Fund and the Adviser hereby appoint the Sub-Adviser to provide investment advisory services to the Fund and the Adviser for the period and on the terms set forth in this Agreement. The Sub-Adviser accepts such appointment and agrees to render the services herein set forth, for the compensation herein provided. The Sub-Adviser shall for all purposes herein be deemed to be an independent contractor of the Adviser and shall, unless otherwise expressly provided herein or authorized by the Adviser or the Board from time to time, have no authority to act for or represent the Adviser or the Fund in any way or otherwise be deemed an agent of the Adviser or the Fund.
2.Sub-Adviser’s Duties. Subject to the general supervision of the Board and the Adviser, the Sub-Adviser shall manage the selection of securities and investments (including cash) for the Fund, including the purchase, retention and disposition thereof, consistent with the Fund’s investment objectives, policies and restrictions as stated in the currently effective prospectus and statement of additional information of the Fund (collectively, the “Prospectus and SAI”), as the same may be hereafter modified, amended and/or supplemented, and subject to the following understandings:
(a) The Sub-Adviser shall consult with the Adviser on the investment program for the Fund and what investments or securities will be purchased, retained or sold by the Fund and what portion of the assets belonging to the Fund will be invested or held uninvested as cash, in accordance with the terms of this Agreement (the “Strategy”).
(b) The Sub-Adviser will assist the Fund and the Adviser in determining or confirming, consistent with the policies and procedures stated in the Prospectus and SAI or adopted by the Board, the value (including determinations of fair value under the 1940 Act) of any securities or other instruments held in the Fund. In this regard, the Sub-Adviser shall respond promptly to any request from the Adviser or the Fund for assistance in obtaining price sources for securities held by the Fund or determining a price when the Adviser and the Fund do not receive a timely, reliable price from the Fund’s pricing agent or source for a security held by the Fund, and will, in response to such a request, promptly review the prices used by the Fund’s administrator and the Fund’s accountant to determine net asset value and advise the Adviser promptly if any price appears to be incorrect.
(c) The Sub-Adviser will: (1) direct the manner in which proxies solicited by issuers of securities beneficially owned by the Fund shall be voted, and (2) make any elections relative to any mergers, acquisitions, tender offers, bankruptcy proceedings or other type events pertaining to the securities held by the Fund. In connection therewith, the Sub-Adviser shall provide disclosure regarding its proxy voting policies and procedures in accordance with the requirements of Form N-1A for inclusion in the Fund’s Registration Statement on Form N-1A covering shares of the Fund or any amendment thereof or any supplement thereto (the “Registration Statement”). The Sub-Adviser shall certify at least annually or more often as may reasonably be requested by the Adviser, as to its compliance with its proxy voting policies and procedures and applicable federal statutes and regulations.
(d) Upon the Adviser’s reasonable request, the Sub-Adviser shall: (i) review and comment upon selected portions relating to the Sub-Adviser and/or the Strategy in the Prospectus and SAI, and will update any information provided in response to a request under this subsection (i) that, to the Sub-Adviser’s knowledge, requires such updating for accuracy from time to time; and (ii) participate, at the reasonable request of the Adviser, in educational meetings with placement agents and other intermediaries about portfolio management and investment-related matters of the Fund.
(e) The Adviser and the Sub-Adviser shall promptly provide notice to each other regarding any inspections, notices or inquiries from any governmental, administrative or self-regulatory agency, including without limitation, any deficiency letter, responses to deficiency letters or similar communications or actions relating to: (i) the management or operations of the Fund or that otherwise relate to the Fund; or (ii) that involve matters that could reasonably be viewed as material to the Adviser’s or the Sub-Adviser’s ability to provide services to the Fund. To the extent that such inspections, notices, or inquiries relate to the Fund, each party shall promptly make available such documents to the other unless, in the opinion of the party’s counsel, the party be legally prohibited from doing so.
3.Custodian and Brokerage Direction. The Fund will establish and maintain an account with a custodian (the “Custodian”) chosen by the Fund and noticed to the Sub-Adviser from time to time. Subject to the oversight of the Adviser, the Sub-Adviser is authorized: (a) to give instructions to the Custodian with respect to transactions for the Fund and its account; and (b) to select brokers or dealers that will execute the purchases and sales of portfolio securities for the Fund. With respect to brokerage selection, the Sub-Adviser shall seek to obtain the best overall execution for Fund transactions, which is a combination of price, quality of execution and other factors. The Sub-Adviser may, in its discretion, purchase and sell portfolio securities from and to brokers and dealers who provide the Sub-Adviser with brokerage, research, analysis, advice and similar services, and the Sub-Adviser may pay to these brokers and dealers, in return for such services, a higher commission or spread than may be charged by other brokers and dealers, provided that the Sub-Adviser determines in good faith that such commission is reasonable in terms either of that particular transaction or of the overall responsibility of the Sub-Adviser to the Fund and its other clients and that the total commission paid by the Fund will be reasonable in relation to the benefits to the Fund and its other clients over the long-term.
4.Compensation of the Sub-Adviser. For the services provided and the expenses borne pursuant to this Agreement, the Adviser will pay to the Sub-Adviser as full compensation therefor a fee, paid quarterly, equal to seventy-five percent (75%) of the advisory fees payable by the Fund to the Adviser under the Fund’s investment advisory agreement with the Adviser (the “Advisory Fee”); provided, however, that the Adviser may reduce the Advisory Fee before calculating the sub-adviser’s fee by deducting certain expenses historically incurred by the Adviser that include the following: administration, account-based and asset-based fees or sub-transfer agency fees, directors fees, legal fees, accounting fees and similar fees, to the extent consistent with past practice, subject to an annual cap of $30,000. For the sake of clarity, taxes on net income received by Advisor and Sub-Advisor shall be the sole responsibility of the applicable party. The sub-advisory fee for each quarter will be paid to the Sub-Adviser within 5 business days of receipt by the Adviser of the Adviser’s fee for the quarter. The Adviser is solely responsible for the payment of the Sub-Adviser’s fees, and the Sub-Adviser agrees not to seek payment of its fees from the Fund. The Sub-Adviser shall pay its own expenses incurred in performing its obligations hereunder.
5.Duration and Termination.
(a) This Agreement shall become effective following the approval of this Agreement by the shareholders of the Fund, expected on or about July 1, 2019. This Agreement shall continue in effect for a period of two (2) years from the effective date, and shall continue in effect from year to year, subject to the termination provisions and all other terms and conditions hereof.
(b) This Agreement may be terminated at any time by the Adviser, without the payment of any penalty, on at least sixty (60) days’ prior written notice to the Sub-Adviser by determination of the Adviser or the vote of the Board of the Fund. Notwithstanding the foregoing, this Agreement will automatically terminate, without the payment of any penalty, in the event this Sub-Advisory Agreement is assigned (as defined in the 1940 Act). This Agreement will also terminate upon written notice to the other party that the other party is in material breach of this Agreement, unless the other party in material breach of this Agreement cures such breach to the reasonable satisfaction of the party alleging the breach within thirty (30) days after written notice.
(c) The Sub-Adviser may terminate this Agreement at any time, without the payment of any penalty, on at least sixty (60) days’ prior written notice to the Adviser and the Fund.
(d) Termination of this Agreement and/or the services of the Sub-Adviser will not affect: (i) liabilities or obligations of the parties for transactions initiated before termination of this Agreement; or (ii) the Fund’s obligation to pay advisory fees to the Adviser, and Adviser’s obligation to pay Sub-Adviser, for fees earned during the term of this Agreement.
6.Good Standing. The Adviser and Sub-Adviser hereby each warrant and represent to the other that it is, and during the term of the Agreement shall continue to be, an investment adviser in good standing, that its respective regulatory filings are current and accurately reflect its advisory operations, and that it is in compliance with applicable state and federal rules and regulations pertaining to investment advisers. In addition, the Adviser and Sub-Adviser further each warrant and represent to the other that neither is (nor are any of their respective “associated” persons, as defined in the Advisers Act) subject to any statutory disqualification set forth in Sections 203(e) and 203(f) of the Advisers Act (or any successor Advisers Act sections or rules), nor are they currently the subject of any investigation or proceeding which could result in statutory disqualification. The Adviser and Sub-Adviser acknowledge that their respective obligations to advise the other with respect to these warranties and representations shall be continuing and ongoing, and should any representation change for any reason, each warrants to advise the other immediately in writing, together with providing the corresponding pertinent facts and circumstances. Further, the Adviser and Sub-Adviser shall comply in all material respects at all times with the 1940 Act and the Advisers Act, all applicable rules and regulations under such Acts and all other applicable law in connection with services to the Fund.
7.Notices. All notices required or permitted to be given hereunder shall be given by Federal Express or comparable courier service and shall be deemed given when delivered. Notices shall be addressed as follows:
Adviser and the Fund:
Copley Financial Services Corp.
c/o David Faust, President
Gallet Dreyer & Berkey, LLP
845 Third Avenue, 5th Floor
New York, NY 10022
with a copy (which shall not constitute notice) to:
Adam Berkey
Gallet Dreyer & Berkey, LLP
850 Third Avenue, 5th Floor
New York, NY 10022
Sub-Adviser:
DCM Advisors, LLC
470 Park Avenue South, 9th Floor
New York, NY 10016
Attn: Andrew M. Greenstein
with a copy (which shall not constitute notice) to:
Thomas W. Steed III
Kilpatrick, Townsend & Stockton LLp
4208 Six Forks Road, Suite 1400
Raleigh, NC 27609
8.Indemnification; Standard of Care.
(a) The Fund agrees to indemnify and hold harmless the Sub-Adviser, any affiliated person of the Sub-Adviser (including, without limitation, any manager, member, employee or agent of the Sub-Adviser), and each person, if any, who, within the meaning of Section 15 of the Securities Act of 1933, as amended (“1933 Act”), controls (“Controlling Person”) the Sub-Adviser (all of such persons being referred to as “Sub-Adviser Indemnified Persons”) against any and all losses, claims, damages, liabilities (excluding salary charges of employees, officers or partners of the Sub-Adviser), or litigation (including legal and other) expenses to which a Sub-Adviser Indemnified Person may become subject arising out of this Agreement; provided, however, that in no case shall the indemnity in favor of the Sub-Adviser Indemnified Person be deemed to protect such person against any liability to which any such person would otherwise be subject by reason of any bad faith, willful misfeasance or gross negligence in the discharge of its obligations and the performance of its duties under this Agreement.
(b) The Sub-Adviser agrees to indemnify and hold harmless the Fund and its officers and directors (each, a “Fund Indemnified Person” and, together with each Sub-Adviser Indemnified Person, an “Indemnified Person”) against any and all losses, claims, damages, liabilities (excluding salary charges of employees, officers or partners of any agent of the Fund), or litigation (including legal and other) expenses to which the Fund Indemnified Person may become subject arising out of the Sub-Adviser’s selection of investments for the Fund that are not permitted by the Strategy; provided, however, that in no case shall the indemnity in favor of a Fund Indemnified Person be deemed to protect such person against any liability to which any such person would otherwise be subject by reason of any bad faith, willful misfeasance or gross negligence in the discharge of its obligations and the performance of its duties under this Agreement.
(c) Notwithstanding the foregoing, no party obligated to provide indemnification hereunder (each, an “Indemnifying Party”) shall be liable for indemnification under this Section 8 with respect to any claim made against an Indemnified Person unless and until such Indemnified Person shall have notified the Indemnifying Party in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Person (or such Indemnified Person shall have received notice of such service on any designated agent); provided, however, that failure to notify an Indemnifying Party of any such claim in a timely manner shall not relieve an Indemnifying Party from any liability which it may have to the Indemnified Person against whom such action is brought except to the extent the delay prejudices the Indemnifying Person. In a case where any such action is brought against an Indemnified Person, the Indemnifying Person will be entitled to participate, at its own expense, in the defense thereof or, after notice to the Indemnified Person, to assume the defense thereof, with counsel satisfactory to the Indemnified Person. If the Indemnifying Person assumes such defense, but the selection of counsel by the Indemnifying Person to represent both the Indemnified Person and the Indemnifying Person results or is reasonably likely to result in a conflict of interests or such counsel would not, in the reasonable judgment of the Indemnified Person, adequately represent the interests of the Indemnified Person, the Indemnifying Person will at its own expense assume the defense of the Indemnified Person with counsel to the Indemnified Person and, also at its own expense, pay for separate counsel to the Indemnifying Person, which counsel shall be satisfactory to the Indemnifying Person and the Indemnified Person. Absent the conflict circumstance described above, the Indemnified Person will bear the fees and expenses of any additional counsel retained by it, and the Indemnifying Person shall not be liable to the Indemnified Person under this Agreement for any legal or other expenses subsequently incurred by the Indemnified Person independently in connection with the defense thereof, other than reasonable costs of investigation. The Indemnifying Person shall not have the right to compromise or settle any litigation, threatened litigation or similar matter involving the Indemnified Person without the prior written consent of the Indemnified Person.
(d) The Sub-Adviser assumes no responsibility under this Agreement other than to render the services called for hereunder. The services of the Sub-Adviser under this Agreement are not exclusive, and the Sub-Adviser is free to provide similar services to other clients of the Sub-Adviser (including, without limitation, other investment companies registered under the 1940 Act). The Sub-Adviser shall not be liable for any error of judgment or for any loss suffered by the Fund or the Adviser in connection with the matters to which this Agreement relates, except a loss resulting from bad faith, willful misfeasance or gross negligence on its part in the performance of its obligations and duties under this Agreement.
9.Notice of Key Staff Changes. The Adviser agrees to notify the Sub-Advisor of any changes in key professional staff at the Adviser, and the Sub-Adviser agrees to notify the Adviser of any changes in key professional staff at the Sub-Adviser, 30 days before such change where practicable or, if not practicable (e.g., the change is due to unexpected professional staff departures), as soon as reasonably practicable under the circumstances.
10.Governing Law. The parties submit to the exclusive jurisdiction of the Federal and state courts in the State, City and County of New York for any dispute arising with regard to this Agreement and matters addressed herein. This Agreement shall be governed by and construed in accordance with the laws of the State of New York notwithstanding the conflict of laws principles thereof.
11.Amendment. This Agreement may be amended, modified or terminated only by written instrument or written instruments signed by the parties hereto. No Act, omission or course of dealing shall be deemed to constitute an amendment, modification or termination hereof.
12.Headings. The heading contained in this Agreement are provided for convenience only and form no part of this Agreement and shall not affect the construction or interpretation of this Agreement.
13.Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their officers designated below as of the date and year first above written.
Copley Financial Services Corp. | DCM Advisors, LLC |
| | | | | |
By: | | | By: | | |
| | | | | |
Name: | David Faust | | Name: | Andrew M. Greenstein | |
| | | | | |
Title: | President | | Title: | Manager | |
| | | | | |
Copley Fund, Inc. |
| | | | | |
By: | | | | | |
| | | | | |
Name: | David Faust | | | | |
| | | | | |
Title: | President | | | | |